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Sumário  
 
O cancro é considerado como um dos maiores problemas de saúde pública em 
todo o mundo (Siegel et al., 2012).De acordo com a Organização Mundial de Saúde 
(OMS), é definido como um crescimento rápido de células anormais que são capazes de 
invadir qualquer parte do corpo e alastrar-se para outros órgãos, iniciando o processo de 
metastização. 
As metástases são um dos timbres do cancro e são a principal causa de morbilidade 
e mortalidade em doentes com cancro, pelo que o seu estudo é de grande importância 
(Seyfried & Shelton, 2010). 
O sistema nervoso é importante no funcionamento de grande parte dos órgãos do 
corpo humano. O sistema nervoso central (CNS), uma das subdivisões do sistema 
nervoso, é constituído pelo cérebro e pela medula espinal. Ambos encontram-se 
protegidos por três camadas de tecido, as meninges: dura máter, aracnóide e pia máter. 
Entre a segunda e a terceira camada existe um espaço chamado de subaracnoide, que é 
preenchido por vasos sanguíneos e pelo líquido cefalorraquidiano (LCR) (Seeley et al., 
2003). 
O LCR é produzido pelas células ependimárias, num sistema de cavidades do 
cérebro chamados de ventrículos. O conjunto destas células formam a barreira hemato-
encefálica (BHE), responsável pela entrada de metabolites necessários ao normal 
funcionamento neuronal (Seeley et al., 2003). 
O fluído cerebrospinal banha o cérebro e a medula espinal, protegendo o CNS. 
Para além disso, o CSF é responsável pela distribuição de nutrientes e químicos filtrados 
pelo sangue, contribuindo para um balanço iónico estável. Como a sua composição 
depende directamente do metabolismo do cérebro e da funcionalidade e integridade da 
BHE, a análise do CSF pode contribuir para o estudo e a compreensão de desordens que 
afectem o SNC (Seeley et al., 2003; Wishart et al., 2008). 
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As metástases do SNC, uma das desordens do SNC, são definidas como a entrada 
de células tumorais do tumor primário para o SNC. Estima-se que cerca de 10 a 30% dos 
pacientes com tumores primários e mais tarde diagnosticados com metástases no SNC. 
São ainda uma das principais causas de morbilidade e mortalidade (Aragon-Ching & 
Zujewski, 2007; Barnholtz-Sloan et al., 2004; Buckner et al., 2007). 
Actualmente, as técnicas de diagnóstico que existem são citologia, examinação 
neurológica e neuroimagem, técnicas que apresentam um baixo nível de sensibilidade 
(Weston et al., 2011). As principais abordagens de tratamento são excisão cirúrgica, 
radiocirurgia, sensibilizadores de radiação, quimioterapia citotóxica, terapias 
direccionadas e drogas capazes de atravessar o BHE (Aragon-Ching & Zujewski, 2007). 
O porquê destas células terem uma predilecção aumentada para o CNS ainda não 
é totalmente conhecido. A detecção e caracterização de células malignas no LCR poderá 
proporcionar uma melhor compreensão da biologia das metástases através da 
identificação e caracterização das populações de células de cancro capazes de se 
infiltrarem no CSF (Aragon-Ching & Zujewski, 2007). 
O perfil metabólico do CSF usando a técnica de RMN já tem sido estudado no 
sentido de encontrar biomarcadores de desordens do SNC (An et al., 2014; Blasco et al., 
2010; Dunn et al., 2011; Lutz et al. 2007; Meissner et al., 2014; Sinclair et al., 2010; 
Smolinska et al., 2012). A combinação da metabonómica com a técnica de RMN potencia 
a descoberta de novos biomarcadores e a descoberta e compreensão dos mecanismos que 
são responsáveis por essas doenças (Smolinska et al., 2012), incluindo as metástases do 
SNC. 
Com esta tese pretende-se estudar o LCR de pacientes com e sem metástases no 
SNC, usando a técnica de RMN para definir uma “assinatura metabólica” do grau de 
comprometimento e/ou invasão do SNC por células tumorais. Pretende-se ainda estudar 
a progressão tumoral e a importância do microambiente tumoral num modelo murino de 
leucemia exposto a diferentes dietas (normal e rica em colesterol) usando diferentes 
abordagens, incluindo a metabolómica, o estudo dos níveis de expressão génicos e 
proteicos e ainda a análise do ciclo celular e da morte celular. 
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Quanto ao primeiro estudo, foram analisadas por RMN 186 amostras, sendo que 
10 correspondiam a pacientes com metástases no SNC. Foi possível identificar 48 
metabolitos diferentes (incluindo álcoois, aminoácidos, ácidos orgânicos e açúcares), 40 
dos quais encontrados em todas as amostras analisadas. 
A análise multivariada do LCR dos pacientes sem metástases no SNC sugere que 
crianças e adultos apresentam perfis metabólicos distintos, confirmando resultados 
previamente obtidos noutros estudos, mas a influencia deste parâmetro parece ser 
limitada. Tendo em conta estas diferenças, foram também analisados os parâmetros 
género e localização do tumor primário. Nesta análise verificou-se que não existem 
diferenças a nível metabólico entre homens/mulheres e entre os diferentes tipos de tumor 
primário. 
Numa segunda análise multivariada foram analisadas as amostras de paciente com 
e sem metástases no SNC. Os resultados aqui obtidos sugerem que o perfil metabólico 
dos pacientes sem metástases é ligeiramente diferente do perfil dos pacientes com 
metástases no SNC. É possível que outros factores possam estar a influenciar este 
resultado, incluindo o número baixo de amostras incluído no estudo. 
No segundo estudo foram analisadas linhas celulares de leucemia linfoblástica 
aguda (linha celular 697-GFP) injectadas em modelo murino exposto a duas dietas 
diferentes, uma normal e outra rica em colesterol, estabelecidas pelos nossos 
colaboradores no Instituto de Medicina Molecular. 
A análise luminescente dos modelos murinos revelou que aqueles que tinham sido 
expostos previamente a uma dieta rica em colesterol tinha uma maior carga de doença 
que aqueles que tinham passado por uma dieta normal. Estes resultados sugerem que o 
colesterol tem um papel importante na progressão e desenvolvimento tumoral. 
A análise metabolómica por RMN dos extractos aquosos destas células suportam 
os resultados anteriormente obtidos, uma vez que a análise multivariada demonstrou que 
células de murinos expostos a diferentes dietas têm perfis metabólicos diferentes. 
Formato, glucose, creatina, glutamina, lactato, isoleucina, leucina e valina foram os 
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metabolitos que se encontram aumentados nas células de murinos expostos a dieta rica 
em colesterol. 
No sentido de estudar o papel da dieta rica em colesterol no crescimento de células 
leucémica foram também avaliados os níveis de expressão de algumas enzimas-chave que 
pudessem explicar as diferenças encontradas a nível metabólico. Verificou-se que a 
expressão de SGLT1 (transportador de glucose) estava aumentada na linha celular de 
murinos expostos à dieta rica em colesterol, sugerindo que esta enzima poderá esta a 
contribuir significativamente para a entrada de glucose nestas células. A expressão de 
GLUT1, outro transportador de glucose, encontrava-se aumentada nas linhas celulares 
que tinham passado pelos murinos, sugerindo que este gene não está relacionado com a 
presença de glucose nas células de murinos expostos a dieta rica em colesterol, mas 
poderá estar relacionado com a selecção in vivo de células tumorais. 
Sendo que o lactato é considerada uma fonte alternativa de energia nas células 
cancerígenas, a análise da expressão de enzimas envolvidas no metabolismo e transporte 
de lactato foram também estudadas. Os níveis de expressão de LDHA encontravam-se 
aumentados em ambas as linhas celulares que passaram pelos murinos, resultados estes 
que estavam em concordância com os obtidos em GLUT1, visto que uma elevada taxa de 
captação de glucose permite um aumento da taxa de glicólise e, consequentemente, leva 
à produção de lactato catalisada por LDHA. No caso dos transportadores de lactato MCT1 
e MTC4 não foram verificados resultados significativos. 
Sendo que a análise por RMN detectou a presença de glucose nas linhas celulares 
de murinos sujeitos a dieta rica em colesterol, foram avaliados também os níveis de 
expressão de enzimas que fazem parte da gluconeogénese. Aqui verificou-se que 
PFKFB1 estava inibida nestas células, o que sugere que a gluconeogénese poderá ser uma 
das vias envolvidas na acumulação de glucose dentro das células de murinos expostos a 
uma dieta rica em colesterol. Em resumo, estes resultados sugerem que colesterol poderá 
ter um papel importante na progressão e no desenvolvimento tumoral. 
Adicionalmente, a análise da proliferação celular e da apoptose nestas células não 
revelou diferenças entre as diferentes linhas celulares em estudo. 
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Em conclusão, estes estudos podem contribuir na compreensão da patofisiologia 
desta doença, incluindo as propriedades das células tumorais e o microambiente do SNC.  
 
Palavras-chave: líquido cefalorraquidiano (LCR), ressonância magnética nuclear (RMN), tumor 
primário, metástase, metabolómica. 
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Abstract 
Central nervous system (CNS) metastasis is a devastating complication of cancer 
and is associated with high morbidity and poor prognosis. However, the mechanisms that 
underlie CNS invasion by tumor cells are still poorly understood. 
Hence, in this thesis it was studied the CSF of cancer patients with and without 
metastasis in the CNS using NMR approach to define a "metabolic signature" of the 
degree of impairment and/or invasion of the CNS by tumor cells. Metabolomic analysis 
suggests that adults and children have different metabolic profiles. Additionally, it was 
seen that CSF composition is not affected by gender and primary tumor origin. The 
analysis of all CSF samples indicates that CSF without cell invasion has a somewhat 
different metabolic profile from CSF with cell invasion. 
In addition, it was also studied tumor progression and the importance of tumor’s 
microenvironment in a leukemia murine model exposed to different diets (normal and fat 
diet) using different approaches including metabolomics, gene and protein expression and 
analysis of cell cycle and cell death. The metabolic analysis of cell extracts of these cell 
lineages from murine revealed that the type of diet affects more the cell metabolism than 
the localization of the tumor. The gene and protein expression analysis indicated that 
GLUT1 and LDHA may play a role in the in vivo selection of tumor cells. Moreover, 
SGLT1 expression was increased in the cells from mice exposed to fat diet. Additionally, 
gluconeogenesis may be one of the pathways involved in the tumor progression in mice 
exposed to a diet rich in cholesterol. These results support that cholesterol may contribute 
to cancer progression and development. 
Overall, these studies may help in understanding the pathophysiology of this 
disease, including the site-specific properties of tumor cells and the CNS 
microenvironment. 
Keywords: cerebrospinal fluid, nuclear magnetic resonance, primary tumor, metastasis, 
metabolomics. 
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1. Introduction 
 
1.1. Overview of Cancer 
Cancer is considered a worldwide public health problem (Siegel et al., 2012). 
According to World Health Organization (WHO), cancer is described as a rapid growth 
of abnormal cells that can invade any part of the body and spread to the surrounding 
tissues and distant organs, initiating the metastatic process. Metastasis are the principal 
cause of morbidity and mortality in cancer patients (Seyfried & Shelton, 2010). 
In 2012, WHO estimates 14.1 million new cancer cases worldwide, 8.2 million 
cancer deaths and 32.6 million people living with cancer (within 5 years of diagnosis). 
Statistics also say that most cases occurred in developing regions as 57% (8 million) of 
new cancer cases, 65% (5.3 million) of the cancer deaths and 48% (15.6 million) of the 
5-year prevalent cancer are reported from these areas. The most deathly cancers are lung 
(1.59 million deaths), liver (745 000 deaths), stomach (723 000 deaths), colorectal (694 
000 deaths), breast (521 000 deaths) and oesophageal cancer (400 000 deaths) (Ferlay et 
al., 2013). 
An important research line in cancer is understanding the biological process 
underlying the passage of normal cells to malignant cancer cells, and what are the changes 
in its cell physiology (Seyfried & Shelton, 2010). 
Hanahan and Weinberg suggested that six main alterations in cell physiology can 
underlie malignant cell growth of nearly all type of cancers (Hanahan and Weinberg, 
2000). These six alterations, also called “hallmarks” are: self-sufficiency in growth 
signals, insensitivity to growth under inhibitory signals, resistance to cell death 
(apoptosis), replicative immortality, angiogenesis and tissue invasion and metastasis 
(Hanahan & Weinberg, 2000; Seyfried & Shelton, 2010). In a recent review, two 
hallmarks were added to this list: reprogramming of energy metabolism and evasion of 
immune system (Hanahan & Weinberg, 2011). Additionally, tumors exhibit another 
dimension of complexity: they can recruit normal cells that contribute to the acquisition 
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of hallmark traits by creating the “tumor microenvironment”. In resume, malignant 
transformation is conditioned by tumor microenvironment (Hanahan & Weinberg, 2011).  
Metastasis, one of the hallmarks of cancer, is the main causes of death in cancer 
and consequently its study is of great importance. This process involves a complex series 
of sequential and interrelated steps. In order to complete the metastatic cascade, cancer 
cells must detach from the primary tumor, intravasate into the circulation and lymphatic 
system, evade immune attack, extravasate at a distant capillary bed, and invade and 
proliferate in distant organs (Bacac & Stamenkovic, 2008; Chamberset al., 2002; Duffy 
et al., 2008; Fidler, 2003; Steeg, 2006). Metastatic cells are also capable of establishing 
a microenvironment that facilitates development and proliferation and lead to the 
formation of macroscopic malignant secondary tumors. Although these major steps of 
metastasis are well studied, the knowledge process that underlies the capacity of 
metastatic cells arise from populations of non-metastatic cells of the primary tumor is still 
very low (Pawelek, 2008; Steeg, 2006, Steeg, 2008). 
 
1.2. Central Nervous System (CNS) metastasis: biology, incidence, 
metabolism and current approaches 
The nervous system (NS) is involved in most of the organic functions of human 
body. This system is subdivided in two parts: the central nervous system and the 
peripheral nervous system (Seeley et al., 2003). 
The central nervous system (CNS) is constituted by the brain and the spinal cord. 
The brain is located inside the cranium and the spinal cord is housed within the spinal 
canal, formed by the vertebrae. The brain and spinal cord are in continuity with each other 
through the foramen magnum. The spinal cord extends from the foramen magnum down 
to the level of the second lumbar vertebra region where this narrows into a cone, forming 
the conus medullaris (Seeley et al., 2003). 
Three layers of tissue, called meninges, surround and protect the brain (Figure 1) 
and the spinal cord (Figure 2). The most superficial layer, dura mater, is thick and 
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surrounds the brain, spinal cord and spinal nerves, being separated from the vertebral 
canal by the epidural space, a space that contains blood vessels, connective tissue and fat. 
The second meningeal layer is called the arachnoid and is very thin and slender. The space 
between arachoid and the dura mater is the subdural space. This layer contains only a 
small amount of serous fluid. The third meningeal layer is called the pia mater. It binds 
very tightly to the surface of the brain and spinal cord. The space formed between the 
arachnoid layer and the layer pia mater is called subarachnoid space and it is filled by 
blood vessels and the cerebrospinal fluid (CSF) (Seeley et al., 2003). 
 
 
Figure 1 - Representation of the meningeal sheaths surrounding the brain (Seeley et al., 2003). 
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Figure 2 - Representation of the meningeal sheaths in the spinal cord (Seeley et al., 2003). 
 
Within the brain there is a system of void cavities called ventricles. The network 
of linked cavities in the brain (cerebral ventricles) is continuous with the central canal of 
the spinal cord. The ventricles are filled with cerebrospinal fluid which is produced by 
specialized epithelium (ependymal cells) located within the ventricles. The ependymal 
cells and the associated support tissues and blood vessels form the choroid plexus. The 
endothelial cells of the choroid plexus, which are connected by tight junctions, form the 
blood-brain barrier (BBB) or blood-CSF barrier. This barrier allows the passage of water, 
some gases and lipid soluble molecules by passive diffusion, and the passage of glucose, 
amino acids and other metabolites essential for normal neural function (Seeley et al., 
2003). 
CSF composition is similar to that of blood serum, cleared of most of its protein 
content. It bathes the brain and the spinal cord, constituting a protective cushion around 
the CNS. Besides its protective role, CSF has an important role the distribution of the 
nutrients and chemicals filtered by the blood, contributing to a stable ionic balance. Since 
its composition depends directly of the brain metabolism and the BBB function and 
integrity, metabolomic analysis of CSF can offer a deeper understanding of the disorders 
affecting the CNS (Seeley et al., 2003; Wishart et al., 2008). 
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CNS metastasis are defined as the spread of cancer cells from the original 
(primary) tumor to the CNS. At macroscopically level, metastatic lesions are usually 
sharply demarcated, spherical masses that often do not infiltrate the surrounding brain 
parenchyma, but cause edema due to mass effect (Pekmezci & Perry, 2013). 
Metastases of the CNS are a frequent complication and cause of death of solid 
tumors. Despite of the use of surgery or radiation therapy for the initial control of the 
primary solid tumor, the development of CNS metastases can still lead to a high mortality 
rate and affects the survival, neurocognition, speech, coordination behavior and life 
quality (Barnholtz-Sloan et al., 2004; Buckner et al., 2007). 
It is estimated that 10 to 30% of patients with solid tumors are later diagnosed 
with CNS metastases. CNS metastasis risks changed with the type of primary cancer, 
being the most prone, in solid tumor: lung, breast, melanoma, kidney and colorectal 
(Aragon-Ching & Zujewski, 2007; Barnholtz-Sloan et al., 2004). 
The incidence of brain metastases has been increasing mainly due to the life span 
expansion and an increase in the number of elderly people which stimulated the urge to 
development the detection of subclinical disease with better imaging and better control 
of systemic disease (Aragon-Ching & Zujewski, 2007). 
The current approaches to detect the spread of cancer into the CSF are cytology, 
neurologic examination and neuroimaging. Even though the combination of these 
methods can increase the accuracy of the diagnosis, the level of sensitivity of these 
methods remains low, delaying treatment (Weston, Glantz, & Connor, 2011). 
The major treatment approaches for CNS metastases are surgical excision, 
radiosurgery, radiation sensitizers, cytotoxic chemotherapy, targeted therapies and drugs 
capable of crossing the BBB (Aragon-Ching & Zujewski, 2007). 
Why tumor cells have an increased predilection for the nervous system is not yet 
fully understood, but the incidence of brain metastases from different cancers appears to 
be increasing and the mechanisms involved are unknown, although it is considered that 
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there are different factors playing an important role in the process (Aragon-Ching & 
Zujewski, 2007). 
The mechanisms of dissemination of cancer cells through the CSF are poorly 
studied. Detection and characterization of malignant cells in the CSF may proportionate 
a better understanding of the metastatic spread biology through identification and 
characterization of the cancer cell populations capable of infiltrating the CSF (Weston et 
al., 2011). 
Tumor cells may reach the CSF through hematogenous spread, direct extension 
from the tumor itself or by migration along perineural 1 or perivascular 2 spaces (Weston 
et al., 2011). However, in rare cases, neoplasms can reach to the CNS by spread via 
cranial nerves, especially in squamous cell carcinomas (SCC) of the head and neck region 
and malignant salivary gland neoplasms (Nussbaum et al., 1996; Spencer et al., 2005). 
The majorly of tumor cells reach the brain via the pulmonary arterial circulation, either 
as a primary lung cancer or a metastasis to the lung from other systemic primaries. The 
majority of the brain metastases are parenchymal, but metastases to 
leptomeninges/subarachnoid space, dura and skull are not uncommon. Additionally, 
approximately 80% of brain metastases are located in the cerebral hemispheres, 15% in 
the cerebellum, and 5% in the brain stem (Patchell, 2003). Other rare sites include choroid 
plexus, pineal gland, pituitary, and optic nerve. There are also case reports of metastases 
to primary CNS tumors (Takei & Powell, 2009). 
Several studies about acute lymphoblastic leukemia (ALL) have been done. ALL 
is an acute form of leukemia characterized by the overproduction of cancerous immature 
white blood cells (the lymphoblasts) in the bone marrow (BM) and peripheral blood (PB) 
and has been a target of several studies with the intuit to better understand the mechanisms 
of dissemination of cancerous cells through the CSF (Barnholtz-Sloan et al. 2004; 
DeVita, et al., 2008). The survival rates of pediatric ALL are above 80%, and 
extramedullary relapses have become extremely rare. The CNS, an important source of 
extramedullary relapse, is a sanctuary site in ALL, due to the role of the BBB in protecting 
                                                 
1
 Cancer spreading to the space surrounding a nerve. 
2
 Cancer spreading to the space surrounding a blood vessel. 
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the CNS from exposure to xenobiotic toxins. To improve relapse-free survival sites in 
ALL, strategies to penetrate the BBB were needed. This led to the use of prophylactic 
cranial irradiation, which was effective in preventing CNS relapse, but it was 
accompanied by major discomfort and potentially severe side effects (Aragon-Ching & 
Zujewski, 2007; DeVita et al., 2008; Pui & Evans, 2006; Pui, 2006; Weston et al., 2011). 
CNS study is difficult and study its disorders using human subjects are somewhat 
limited, because of evident ethical and practical reasons. To overcome this limitation, 
researchers have developed model systems to study the brain metastasis and to gain 
mechanistic insights into the brain metastasis pathogenesis. The use of model animals 
gave an enormous impact in how brain tumor perfusion, angiogenesis, metabolism and 
response to therapy can be approached (Gillies et al., 2000). Neverthless, Palmieri and 
co-workers (2007) describe that although rodent systems were developed for brain 
metastasis in melanoma, lung carcinoma and breast carcinoma, they are not sufficient to 
represent the heterogeneity of CNS metastasis observed in the clinic. In addition, almost 
no comparison has been made between the molecular characteristics of model systems 
and the clinical CNS metastasis (Aragon-Ching & Zujewski, 2007; Palmieri et al., 2007). 
Initially, cancer cells that constitutes tumors have been portrayed as reasonably 
homogeneous cell populations until relatively late in the course of tumor progression, 
when hyperproliferation combined with increased genetic instability results in a distinct 
clonal subpopulations (Hanahan and Weinberg, 2011). Additionally, Wu and co-workers 
(2012) verified that, in human meduloblastoma (a histological type of brain tumor), 
metastasis of an individual are extremely similar but a significant level of heterogeneity 
is observed from this cells to the ones found in the primary tumor. The bi-compartimental 
nature of metastatic medulloblastoma is an obstacle to the development of effective 
targeted therapies (Clifford, 2012; Wu et al., 2012) and more studies are needed to further 
understand the pathophysiology of CNS metastasis regarding site-specific properties of 
the tumor cell and its microenvironment. The goal is to develop new and improve directed 
therapies to effectively eliminate these toxic and deathly cells (Aragon-Ching & 
Zujewski, 2007). 
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1.3. Metabolic profiling of CSF and metastatic cells using nuclear 
magnetic resonance (NMR) spectroscopy 
 
Metabolic profiling is the measurement in biological systems of the complement 
of low-molecular-weight metabolites and their intermediates that reflects the dynamic 
response to genetic modification and physiological, pathophysiological, and/or 
developmental stimuli (Beckonert et al., 2007). 
Metabonomics and metabolomics appeared at the end of the 90’s and early 2000’s, 
respectively (Nicholson et al., 1999; Oliver, Winson, Kell, & Baganz, 1998). 
Metabonomics is defined as the “quantitative measurement of the dynamic 
multiparametric metabolic response of living systems to pathophysiological stimuli or 
genetic modification” (Nicholson et al., 1999). For Metabolomics it is used a very similar 
definition: “study of the quantitative complement of metabolites in a biological system 
and changes in metabolite concentrations or fluxes related to genetic or environmental 
perturbations” (Dunn et al., 2011). In the literature, both terms are very often used 
interchangeably. The concept of metabonomics may be viewed, in part, as a successor of 
the term metabolomics (Ellis, Dunn, Griffin, Allwood, & Goodacre, 2007; Fiehn, 2002; 
Nicholson et al., 1999). 
There are two possible approaches that can be used in metabolic profiling, a 
targeted or a global non-targeted analysis of metabolites (endogenous3 or exogenous) for 
the discovery of disease diagnosis biomarkers or drug effects (Lindon et al., 2004; 
Nicholson & Lindon, 2008). According to the official National Institutes of Health, 
biomarker is defined as ‘characteristic that is objectively measured and evaluated as an 
indicator of normal biologic processes, pathogenic processes, or pharmacologic responses 
to a therapeutic intervention’ (Atkinson et al., 2001). This includes both metabolites and 
metabolic profiles. Biomarkers have emerged as an attractive and valuable tool for 
                                                 
3 Intracellular metabolites, including aminoacids, amines, sugars, steroids, nucleic acid bases and other 
substances that function as intermediates of cell metabolism. 
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accurate diagnose of diseases. In the case of metabolic profiles, they can be particularly 
useful for comparison between healthy and dysfunctional systems in the early stage of 
disease and therefore provide new possibilities for preventing therapies (Smolinska et al., 
2012). 
Metabolic profiling is a developing field since the number of target studies have 
been increasing. This type of approach has been fundamental to the development of many 
areas of biomedical research, like toxicology studies, nutritional effects, metabolic 
consequences of genetic modifications, inborn errors of metabolism, diabetes, cancer 
diagnostics and diagnostic of neurological diseases (Beckonert et al., 2007; Beger, 
Schnackenberg, Holland, Li, & Dragan, 2006; Blasco et al., 2010; Bogdanov et al., 2008; 
Coen, Holmes, Lindon, & Nicholson, 2008; Constantinou et al., 2005; Ellis et al., 2007; 
Gowda et al., 2008; Hori et al., 2011). 
Metabolic profiling studies were been performed in diverse biomatrices: plasma, 
urine, seminal fluid, saliva, CSF, lung aspirates, gastrointestinal fluids, bile, tears, fluids 
obtained from cysts and blisters, amniotic fluid, synovial fluid, dialysis fluid, tissue 
specimens and tissue extracts (Beckonert et al., 2007; Lindon et al., 2007). 
The identification of biochemical biomarkers in biofluids for CNS disorders, such 
as amyotrophic lateral sclerosis, multiple sclerosis, alzheimer, parkinson and cancer, has 
been a target of metabolomics studies (An et al., 2014; Blasco et al., 2010; Bogdanov et 
al., 2008; Kork et al., 2009; Kumar et al., 2010; Lutz & Cozzone, 2011; Meissner et al., 
2014; Sinclair et al., 2010; Wishart et al., 2008). 
Nowadays, the diagnostic of most of the neurological diseases is based on the list 
of symptoms, but most times it is difficult to rapidly obtain an accurate diagnosis. Since 
the complexity of this type of diseases probably arise from molecular and 
microenvironment alterations, it is possible that changes in the metabolic profiles can be 
found (Quinones & Kaddurah-Daouk, 2009; Smolinska et al., 2012). 
Metabolomic study is suited for brain research since small molecules play 
fundamental roles (Holmes et al. , 2006). Since the CSF composition depends directly on 
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the rate of production of metabolites in the brain, metabolomic analysis of CSF can offer 
perspectives in biochemical CNS disorders (Seeley et al., 2003; Wishart et al., 2008).  
For biomarker discovery, it is important discriminate the meaningful data from 
metabolic profiles of biofluids. Chemometrics can be useful to identify relevant 
metabolites. There are several different mutltivariate techniques that allow exploration, 
visualization, classification and prediction of the data. Nowadays, there are different 
analytical platforms that are commonly used for metabolic profiling. This includes 
nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS) based 
techniques, such as gas chromatography-mass spectrometry (GC-MS) and liquid 
chromatography-mass spectrometry (LC-MS). All these techniques have their advantages 
and disadvantages (Smolinska et al., 2012). 
Nuclear magnetic resonance (NMR) spectroscopy is a physical phenomenon in 
which nuclei in a magnetic field absorb and re-emit electromagnetic radiation.  NMR 
spectroscopy possesses many attributes of an ideal platform for metabolic profiling. This 
includes minimal sample pre-treatment and is untargeted, quantitative, high 
reproducibility, not-destructive and unbiased. Although NMR spectroscopy is less 
sensitive than MS-based techniques, the availability of cryogenic NMR probes and 
spectrometers with higher magnetic fields has improved the sensitivity. NMR is also 
capable of detect compounds that are too volatile for GC-MS (Dumas et al., 2006; Keun 
et al., 2002; Smolinska et al., 2012). In a study, Wishart and co-workers (2008) verified 
that NMR was the technique that can detect more metabolites (53 metabolites, 21 unique 
of this technique), as demonstrated in figure 3, although it is more advantageous the 
combination of different techniques to be possible the identification of more metabolites. 
The authors conclude that NMR appears to be the best method for performing global or 
non-targeted metabolic profiling of CSF (Wishart et al., 2008). 
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. 
Figure 3 -Venn diagram showing the overlap of CSF metabolites detected by global NMR, GC–MS and 
LC–FTMS methods compared to the detectable CSF metabolome (Wishart et al., 2008). 
 
Metabolic profiling of CSF using NMR has been performed to find diagnostic 
biomarkers for CNS disorders (An et al., 2014; Blasco et al., 2010; Dunn et al., 2011; 
Lutz et al., 2007; Meissner et al., 2014; Sinclair et al., 2010; Smolinska et al., 2012). This 
potentiates biomarker discovery and also contribute to uncover disease mechanism that 
underlie this complex neurological diseases (Smolinska et al., 2012), including CNS 
metastases. 
The use of metabonomics based on NMR also allows the characterization of cell 
metabolome in intact cells or cells extracts and interpret them in terms of metabolic 
changes in a wide range of situations, in order to begin to explain the more complex 
metabolic pathways occur in the body (Duarte et al., 2009). Moreover, much research 
work has focused on metabolic differentiation between tumor and healthy tissue in order 
to find biomarkers for the presence and / or different levels of development of various 
cancers, such as breast, brain, prostate, cervical, colorectal, liver, kidney and gastric 
cancer (Duarte et al., 2010). 
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2. Aims  
 
The first main objective of this master thesis is to study the cerebrospinal fluid 
(CSF) metabolome of cancer patients with and without metastasis in the central nervous 
system (CNS), resorting to nuclear magnetic resonance (NMR), to define a "metabolic 
signature" of the degree of impairment and/or invasion of the CNS by tumor cells. 
The second main objective is to study tumor progression and the importance of 
tumor’s microenvironment in a leukemia murine model exposed to different diets (normal 
and fat diet) using different approaches including metabolomics, gene and protein 
expression and analysis of cell cycle and cell death (apoptosis and necrosis). 
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3. Materials and Methods 
This chapter describes the biological material used for this study and all 
experimental procedures and analysis methods applied in each study. 
 
3.1. Study of CSF from patients with and without CNS metastasis by 
1H NMR spectroscopy 
 
3.1.1. Biological Material 
The cerebrospinal fluid (CSF) samples were collected after the informed consent, 
according the guidelines of Instituto Português de Oncologia Francisco Gentil EPE.  
The CSF samples were obtained from cancer patients with several types of 
primary tumor (leukemia, lymphoma, breast carcinoma, multiple myeloma, 
rhabdomyosarcoma, germ cell tumor, lung cancer, non-melanoma and melanoma) and 
result from the lumbar punction performed for CNS metastasis diagnosis.  
A total of 186 CSF samples were collected and analyzed between September 2013 
and July 2014. For each CSF sample, information about age, gender, types of primary 
tumor and presence or absence of tumor metastasis in CNS of the donor were obtained 
from patients clinical records. The control group was composed by samples from patients 
without the presence cells on the CNS. Cell invasion group was composed by the samples 
from patients with metastatic cell invasion of the CNS. The data concerning the 
population study is in Table 1 and Table 2. 
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Table 1 - Groups of CSF samples subdivided in age and gender. 
Groups of 
patients 
Number of 
patients 
Age Gender 
children adults female male 
Controls 176 99 77 79 97 
Cells invasion 4 10 1 9 5 3 
 
Table 2 -Groups of CSF samples subdivided in type of tumor and then in age. 
Groups of 
patients 
Type of primary tumor 
children adult 
Controls 
93 leukemia 
13 lymphoma 
2 rhabdomyosarcoma 
1 germ cell tumor 
21 leukemia 
46 lymphoma 
5 breast carcinoma 
1 non-melanoma 
3 multiple myeloma 
1 colorectal cancer 
Cells invasion 5 1 leukemia 
2 lymphoma 
1 leukemia 
1 breast carcinoma 
1 lung cancer 
1 melanoma 
1 lymphoma 
 
An arbitrary code was attributed to each sample to ensure the confidentiality of 
the patients after its collection and during the analysis process. 
After collection, the CSF was immediately centrifuged at 1200 rpm at 4°C for 5 
min. The cells and the supernatant were stored at 4°C for two days, after which they are 
placed at -80°C until further analysis. 
                                                 
4
 No information known about the gender of two patients of this group. 
5
 No information known about the type of primary tumor of two patients of this group. 
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CSF samples colored due to blood contamination (xantochromic or 
erythrochromic) were discarded. 
 
3.1.2. Metabolic profiling by NMR spectroscopy 
The schematic representation of the steps involved in this procedure is shown in 
Figure 4. 
 
Figure 4 - Schematic representation of the steps involved in metabolic detection by NMR spectroscopy. 
 
3.1.2.1. Samples preparation 
CSF samples were thawed at room temperature. Each CSF sample (300 µL) was 
diluted with 300 µL of phosphate buffer solution 0.75 M with 2 mM sodium azide (NaN3) 
and 100% of D2O, to minimize inter-sample pH differences and provide a field lock. A 
volume of 550 µL of each prepared sample was then transferred to a 5 mm borosilicate 
NMR tube (NewEra), prior to NMR acquisition. 
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3.1.2.2. Equipment 
The spectral acquisition was performed at CERMAX facility at Instituto de 
Tecnologia Química e Biológica (ITQB-UNL) in Bruker Avance II+ 800 MHz 
spectrometer with 5mm TXI probe, at 298 K. All 1D and 2D experiments were acquired 
and analyzed using Topspin 2.1 software (Bruker). 
 
 
3.1.2.3. Experiments 
1H noesy1d and j-resolved experiments were acquired in all samples. The 
utilization of the noesygppr1d pulse program allowed efficient water suppression, 
necessary for increase the intensities of the other signals on the samples. To in order to 
resolve signal overlapping in the spectra, it was used J-resolved experiment (jresqfpr 
pulse program). Acquisition and processing parameters used during this work were the 
same for all samples, allowing the comparison between samples (Table 3). 
To assist metabolite identification other experiments were performed, such as 1D 
Carr-Purcell-Meiboom-Gill (CPMG), homonuclear 2D (1H correlation spectroscopy 
(COSY) and 1H Total Correlation Spectroscopy (TOCSY)) and heteronuclear 2D 1H-13C 
Heteronuclear Single Quantum Correlation (HSQC)) experiments.  
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Table 3 – Acquisition and processing parameters of the experiments performed for all samples. 
1H Noesy 
(noesygppr1d) 
J-resolved 
(jresqfpr) 
Acquisition parameters 
NS = 128 
DS = 4 
RD = 5 s 
SW = 16025,64 Hz 
TD = 128K points 
Tm = 100 ms 
NS = 1 
DS = 16 
RD = 2 s 
TD[F1] = 40 
TD[F2] = 8192 
SW[F1] =  78,125 Hz 
SW[F2] =  13368,984 Hz 
Processing parameters 
SI = 128K points  
LB = 0.3 Hz  
WDW = exponential  
SI [F1] = 40 
SI [F2] = 8192 
WDW = qsine 
 
 
3.1.2.4. Data processing 
Data processing is an intermediate step between spectra acquisition and data 
analysis necessary for the preparation of the metabolic profiling data to multivariate 
analysis. This step includes phase and baseline correction, chemical shift calibration, 
data-point reduction or “binning”, the removal of redundant spectral regions, peak 
alignment (if necessary) and normalization. 
Phase correction, baseline correction and calibration were carried out manually in 
Bruker TopSpin 2.1 software. The reference used for calibration was the α-glucose 1-H 
resonance at 5.22 ppm. 
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Prior to multivariate analysis, data was organized into two-dimension data tables 
of spectral intensities, in which each line corresponds to a sample and the columns to the 
chemical shifts, using R software application (www.r-project.org/). The spectra organized 
into a matrix were binned, the peaks were aligned with respect to all the peaks across the 
data set, the redundant spectral regions (namely noise regions, the water and urea peaks) 
were removed and the spectra were normalized. 
Spectral binning was used in order to reduce the data dimensionality. This 
involves the averaging the intensities over intervals of 8 points in order to reduce the 
contribution from the noise, thus resulting in the reduction the number of points from 
131072 to 16384 (Savorani et al., 2010; Smolinska et al., 2012). Since there are small 
chemical shifts differences between in some of the peaks of different spectra, peak 
alignment was performed using Cluster-based Peak Alignment (CluPA) algorithm (Vu et 
al., 2011). The water region (4.60 – 4.90 ppm) present in all samples and the urea 
resonance (5.60 - 6.00 ppm). At the end, normalization is performed to take into account 
variations of the total amount of material and dilution of the samples.  
 
3.1.2.5. Spectral assignments 
The metabolite identification was based on the assignments achieved through the 
1D and 2D NMR experiments and by comparison with spectra of pure standards from the 
Human Metabolome Database (HMDB) (Wishart et al., 2007) and BioMagResBank 
(BMRB) (Ulrich et al., 2008) databases, and from the Chenomx NMR suite 7.4 software 
internal database. 
 
3.1.2.6. Multivariate analysis 
Multivariate analysis was performed using SIMCA 13.0.3 software (Umetrics, 
Umeå, Sweden). 
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Firstly, data sets were analyzed using the unsupervised method Principal 
Component Analysis (PCA), which is a method doesn’t take into account any prior 
information of the data. PCA expresses most of the variance within a dataset using a 
smaller number of variables, the Principal Components (PC). The first principal 
component represents as much of the variability of the data as possible and each 
succeeding PC takes into account as much as possible of the remaining variability. The 
analysis of NMR data by PCA results in two plots: the scores and the loadings. The scores 
plot represents a summary of all spectra since each point represents one spectrum, 
showing how related they are to each other and allowing to find trends, groupings and 
outliers. The loadings plots shows which variable from the NMR spectra are responsible 
for the trend observed in the corresponding scores plot (Jolliffe, 2002) 
The supervised multiple regression method used was the Orthogonal Partial Least 
Squares Discriminant Analysis (OPLS-DA). In this model it is possible to compare two 
independent groups of samples and model predictive power was evaluated by Q2 
(goodness of prediction), a parameter obtained from randomly cross-validation of 
samples to avoid overfitting, to obtain the Q2 distributions for the randomly permuted 
samples and for the original class of that samples. After validation, the relevant metabolite 
signals were identified in the loadings plots (Eriksson et al., 2001; Madsen, Lundstedt, & 
Trygg, 2010) 
 
 
3.2. In vitro study of CNS metastasis in human acute lymphoblastic 
leukemia (697-GFP) cell line  
 
3.2.1. Biological Material 
In order to study the tumor progression and the importance of tumor’s 
microenvironment, our collaborators in the Instituto de Medicina Molecular, established 
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a leukemia murine model. Mice were inoculated in the tail vein with cells from 697 cell 
line, a commercial lineage of an in vitro model of Human Pre-B cell leukemia (American 
Type Culture Collection (ATCC)). This cell line was transduced with a luciferase-green 
fluorescence protein (Luc-GFP) reporter gene allowing the in vivo and in vitro 
visualization of the cells in order to evaluate the disease progression in further studies by 
fluorescence microscopy, sorting by fluorescence-activated cell sorting (FACS) analysis 
or luminescence analysis. 
Two groups of mice where maintained with two distinct types of diets: a normal 
and a fat diet (1.2% cholesterol), in order to study the influence of diet in tumor 
metastasis. Leukemia cells were isolated from the places where the cells appeared: skin, 
bone marrow (BM) and brain. The data regarding the diet and the localization of tumor 
metastasis is represented in Table 4. 
 
Table 4 - Diet and localization of tumor cells in mice inoculated with 697-GFP cell line.  
Tumor cells culture Mouse diet Localization of tumor metastasis 
S Normal Skin 
B Normal Brain 
BM Normal Bone marrow 
B2 and B3 Fat Brain 
S1, S2 and S3 Fat Skin 
 
The cell lines were cultured at 37°C in a humidified 5% CO2 environment in RPMI 
1640 medium without L-glutamine (BE12-167F, Lonza). Medium was supplemented 
with 10% fetal bovine serum (FBS) (S 0615, Biochrom), 1% Antibiotic-Antimycotic 
(AA) (15240062, Anti-Anti, Invitrogen) and 1% L-Glutamine (25030-024, Gibco, Life 
Technologies). 
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Cell lines were propagated until approximately 1x106 cell/ml and splitted 1:2 for 
them to continue to grow. Cell number was determined by using a Bürker counting 
chamber (haemocytometer). 
Parental lineages (not inoculated in mice) were grown in parallel and used as 
control. 
 
3.2.2. Metabolic profiling by NMR spectroscopy 
NMR assay was performed to determine the metabolic profile of parental cells 
and cells isolated from mice. 
Cells (1x107) were submitted to starvation in order to synchronize cells in the 
same stage of cell division, being
 
cultured in 40 mL of RPMI 1640 medium (BE12-167F, 
Lonza) supplemented with 1% AA (15240062, Anti-Anti, Invitrogen) and L-Glutamine 
200 mM (25030-024, Gibco, Life Technologies), at 37°C and 5% CO2 without FBS. After 
8 h, culture medium was supplemented with 1% of FBS (S 0615, Biochrom) and 48 h 
later, cells were harvested by centrifugation at 1200 rpm for 3 min at room temperature. 
Afterwards, supernatants (cell media) were collected and stored at -80°C and cell pellets 
washed twice with phosphate buffered saline (PBS). 
A methanol and chloroform extraction was performed in cell pellets, in order to 
extract the organic and the aqueous fractions. It was added 4 ml methanol for 1 g wet cell 
weight and 2 volumes of water. Mixed and incubated on ice for 5 min; 1 volume of 
chloroform was added and mixed, and 1 volume of water was added and incubated on ice 
for 10 min. Finally, samples were centrifuged at 4000 rpm for 15 min at 4°C, the organic 
(lower) and aqueous (upper) phases were collected separately and stored at -20°C until 
they were dried under speed vaccum in a Speed Vac Plus Savant SC110A. 
The aqueous phases were dissolved in 540 µL of D2O with 60 µl of phosphate 
buffer 0.35 M with 2 mM sodium azide (NaN3) in 100% of D2O. Samples were mixed in 
the vortex and transferred to a 5 mm NMR tube (New Era). 
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The organic phases were dissolved in 600 µL of deuterated chloroform (CDCl3), 
mixed in the vortex and transferred to a 5 mm NMR tube (New Era). 
To 300 µL supernatants, 240 µL of D2O and 60 µL of phosphate buffer 0.35 M 
with 2 mM sodium azide (NaN3) in 100% of D2O. The sample was mixed in the vortex 
and transferred to a 5 mm NMR tube (New Era). 
The equipment used was the same as in section 3.1.2.2. The experiments 
performed for the analysis of supernatants and aqueous extracts were the same as in 
section 3.1.2.3. For organic phases, zg pulse program was the standard 1D experiment 
used. The data processing, spectral assignments and multivariate analysis steps were 
similar to those used for CSF samples. 
 
3.2.3. Gene expression 
In order to understand the role of fat diet in leukemia growth and disease burden 
in mice models, the expression of key metabolic genes was evaluated to determine which 
pathways were responsible for the metabolic patterns found in 697-GFP parental cell lines 
and in cells isolated from mice maintained in normal and fat diet. 
The evaluated genes are involved in gluconeogenesis (ALT, PCK1, PCK2, FBP1, 
PFKFB1); lactate metabolism and transport (MCT1, MCT4, LDHA, LDHB, LDHC); 
glucose transport (SGLT1, GLUT1) and the conversion of glutamate into α-ketoglutarate 
(IDH1, IDH2). 
 
3.2.3.1. Reverse transcription polymerase chain reaction (RT-PCR) 
Reverse transcription polymerase chain reaction (RT-PCR) is one of the variants 
in polymerase chain reaction (PCR), mostly utilized in molecular biology to quantify 
mRNA expression levels from biologic samples. This technique is used to synthesize 
single-stranded complementary DNA copy (cDNA) from a RNA template, using a 
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reverse transcriptase. The resulting cDNA is then amplified and quantified by PCR 
(Freeman et al., 1999). 
Total ribonucleic acid (RNA) was extracted from each cell lineage using TRI 
Reagent® (T9424, SIGMA-ALDRICH®), according to the manufacturer’s protocol. 
Samples were stored at -80⁰C. The quantification of RNA was determined in a Nanodrop 
2000 spectrophotometer (Thermo Scientific). 
Total cDNA was synthesized from 1 µg of the RNA extracted and it was 
performed in a T3000 thermocycler (Biometra), according to the program described in 
Table 5. 
 
Table 5 – Program utilized for cDNA synthesis. 
Stage Cycles Temperature (°C) Time (min) 
Denaturation 1 70 10 
Cooling 1 4 5 
cDNA synthesis 1 42 90 
Inactivation 1 75 15 
Cooling - 4 ∞ 
 
 
For each synthesis reaction it was prepared a mix of 8 µL containing 1 µg RNA 
in RNase free water up to 7.5 µL and 0.5 µL random primers (11034731001, Roche). 
This mix was incubated at 70°C for 10 min, for the annealing between RNA and 
the random primers. Afterwards, the temperature was decreased to 4⁰C in order to add a 
second mixture composed by: 4 µl first Strand Buffer 5X (Y02321, Invitrogen), 2 µL 
dithiothreitol 0.1 M (DTT) (Y00147, Invitrogen), 2 µL deoxynucleotides (dNTPs) mix 
(10 mM) (28-4065-22V, 28-4065-02V, 28-4065-12V and 28-4065-32V, GE Healthcare), 
1 µL RNAse OUT™ Recombinant RNase Inhibitor 40 U/ µL (10777-019, Invitrogen), 1 
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µL Superscript II® 200 U/ µL (18064-022, Invitrogen) and double-destilled water 
(ddH2O) in order to have a total volume of 12 µL. 
 
3.2.3.2. Real time quantitative polymerase chain reaction (RQ-PCR) 
Real time quantitative polymerase chain reaction (RQ-PCR) allows the detection 
and measurement of products generated during each cycle of the polymerase chain 
reaction (PCR), process which are directly proportionate to the amount of template prior 
to the start of the PCR process (Ginzinger, 2002). Currently, this technique has various 
applications in many fields of biological research since it permits the analysis of gene 
expression with accuracy, sensitive and fast results, as for example in relative 
quantification of messenger ribonucleic acid (mRNA transcription) (Derveaux et al., 
2010). 
In RQ-PCR, a reaction mixture was prepared for all the genes mentioned in section 
3.2.3 for each cell sample, in triplicates. Each reaction mixture contained 1 µL of cDNA, 
4 µL of Power SYBR® Green PCR master mix (4367659, Applied Biosystems by Life 
Technologies), 3 µL Power SYBR® Green PCR master H2O (4367659, Applied 
Biosystems by Life Technologies), and 0.15 µL of both forward and reverse primers (5 
µM), to a final volume of 7.3 µL per well. 
All samples were run in triplicate (biological triplicates) and 18S rRNA was the 
housekeeping gene used to normalize the results. RQ-PCR was performed in 
LightCycler© 480 instrument (Roche), according to the program ABI389 from Applied 
Biosystems by Life Technologies described in table 6. 
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Table 6 – Program utilized for RQ-PCR. 
Stage Cycles Temperature (°C) Time 
Incubation 1 50 2 min 
Incubation 1 95 10 min 
PCR 
Denaturation 
Annealing 
Elongation 
45 
 
95 
60 
72 
 
15 seconds 
15 seconds 
20 seconds 
Melting curves 1 
95 
60 
95 
15 seconds 
15 seconds 
continuous 
Cooling 1 40 10 seconds 
 
The results obtained in RQ-PCR were analyzed in LightCycler 480 software 
(Roche). Expression levels from each sample were normalized to 18S rRNA and 
relatively quantified to those obtained in the parental lineage. For each cell lineage, 
average and standard deviation of the relative gene expression values were calculated and 
statistical analysis was performed. 
 
3.2.4. Protein levels 
Since the metabolic effectors are proteins, the levels of gluconeogenic proteins 
(ALT, PCK1, PCK2, FBP1 and PFKFB1), lactate transporters (MCT1 and MCT4) and 
conversion of pyruvate into lactate (LDHA and LDHB) were evaluated by western blot 
for all the cell lineages specified in 3.2.1. 
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3.2.4.1. Western Blotting 
Western blotting is a powerful and widely used method for protein detection in 
complex biologic samples. This technique consists in the immunodetection of proteins 
that were previously separated by electrophoresis, transferred onto a membrane and 
detected with specific antibodies (Kurien & Scofield, 2006). 
Cell pellets were collected, centrifuged and washed with Phosphate Buffered 
Saline (PBS). 
To obtain the cytoplasmic proteins, the cell pellet was resuspended with Radio-
Immunoprecipitation Assay (RIPA) buffer (Appendix A) and stored at -20⁰C, where cell 
lysis occurred. For trans-membrane proteins, cell extracts were performed with a 
Mitochondria Isolation Kit (MITOISO2, SIGMA), according to the manufacturer’s 
protocol.  
The lysates were centrifuged at 14000 rpm for 5 min at 4°C. Part of the 
supernatants were used for the determination of protein concentration based on the 
Bradford method, using protein assay reagent (500-0006, Bio-Rad), through 
spectrophotometric quantification at 595 nm. After quantification, Loading Buffer 5X 
(Appendix A) and 10% β-mercaptoethanol (M3148, Sigma-Aldrich®) were added to the 
lysates, and protein was denatured by boiling at 95-100°C for 10 min. The samples were 
then centrifuged at 14000 rpm for 2 min at 4°C and placed on ice. 
From each sample, the same amount of total protein was loaded into a 15% SDS-
polyacrylamide gel (SDS-PAGE) (Appendix A). Electrophoresis was carried out in 
MINI-PROTEAN Tetra Electrophoresis System (Bio-Rad) at 135 V for 1h30 in TGS 
buffer (Tris-Glycine-SDS buffer 10X, 161-0772, BioRad). After electrophoresis the 
proteins were transferred to an Immun-Blot® PVDF membrane with a Mini Trans-Blot® 
Electrophoretic Transfer Cell (BioRad), using transfer buffer (Appendix A), overnight at 
4⁰C and 60 volts. To block non-specific bindings to the membrane 5% (w/v) non-fat milk 
(Molico, Nestlé) in PBS 0.1% (v/v) Tween 20 (Appendix A) was used, incubation 
occured for 2 h at room temperature, with slow shaking. For the detection of the proteins 
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of interest, the membranes were incubated with primary specific antibodies Anti-PCK1 
(R04368, Sigma-Aldrich®), Anti-PFKFB1 (SAB1408617, Sigma-Aldrich®), monoclonal 
anti-rabbit MCT1 (AB3538P, Milipore), monoclonal anti-rabbit MCT4 (SC-50329,  
Santa Cruz),  monoclonal anti-mouse LDHB (WH0003945M1, Sigma-Aldrich®) at 
concentration 1:250 in 5% (w/v) non-fat milk (Molico, Nestlé) in PBS 0.1% (v/v) Tween 
20 (Appendix A), overnight at 4°C, with mild shaking. 
To remove unbound primary antibody, the membranes were rinsed 3 times, for 5 
min, with PBS 0.1% (v/v) Tween 20 (Appendix A). The membranes were then incubated 
with secondary antibody IgG-conjugated Horse raddish peroxidase (HRP) anti-rabbit 
(31460, Thermo Scientific) or anti-mouse (31430, Thermo Scientific) diluted 1:5000 in 
5% (w/v) non-fat milk in PBS 0.1% (v/v) Tween 20 (Appendix A), for 2 h, at room 
temperature. 
After incubation, the membranes were rinsed 3 times, for 5 min, with PBS 0.1% 
(v/v) Tween 20 (Appendix A). Immunoreactive bands were detected by using 
SuperSignal® West Pico Chemiluminescent Substrate (34080, Thermo Scientific) and 
converted to digital images in a ChemiDoc XRS System (BioRad) equipped with Image 
Lab software. 
β-actin was used as endogenous control for protein quantification in the Western-
blot membranes. For this purpose, after development of the bands of interest, the 
membranes were again rinsed 3 times, for 5 min, with PBS 0.1% (v/v) Tween 20 
(Appendix A) and re-incubated overnight at 4°C with anti-β-actin (A5441, Sigma-
Aldrich®) diluted 1:1000 in 5% (w/v) non-fat milk in PBS 0.1% (v/v) Tween 20 
(Appendix A) with mild shaking. Later, the membranes were revealed as describe above 
and converted to digital images. Image J software (rsb.info.nih.gov/ij/) was used to 
analyze and quantify all bands obtained.  
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3.2.4.2. Immunofluorescence 
Immunofluorescence is a technique that uses antibodies labeled with 
fluorochromes to detect specific target antigens within a cell, allowing their visualization 
in a fluorescence microscope (Odell & Cook, 2013).  
Cells were collected and centrifuged at 1200 rpm for 2 min and ressuspended in 
500 µL of PBS. Cell suspensions (100 µL) were transferred onto a glass slide by 
centrifugation in a Citospin at 1200 rpm for 5 min, where it formed  
Cells were fixed with methanol, for 30 min. Each group of cells was delimitated 
with a hydrophobic pen (S2002, Dako) and then was added PBS 0.1% (w/v) BSA 
(Appendix A) for 30 min at room temperature, to block unspecific bindings. Each circle 
(except the negative controls, for secondary antibody specificity) was incubated with 50 
µL of primary antibodies MCT1 (monoclonal anti-rabbit, AB3538P, Milipore) and MCT4 
(monoclonal anti-rabbit, SC-50329, Santa Cruz) diluted 1:100 in PBS 0.1% (w/v) BSA 
(Appendix A), overnight at 4°C, in a humid chamber. In the negative controls it was added 
50 µL PBS 0.1% (w/v) BSA (Appendix A). 
Slides were rinsed with PBS 3 times for 5 min, and incubated with secondary 
antibody Alexa Fluor© 488 anti-rabbit (A-11034, Invitrogen - Life Technologies Inc) 
diluted 1:1000 in PBS 0.1% (w/v) BSA (Appendix A) for 2 h at room temperature, 
protected from light. 
After incubation, slides were rinsed 3 times for 5 min with PBS and then mounted 
with Vectashield mounting medium with DAPI (4’-6-diamidino-2-phenylindole) (H-
1200, Vector Labs) and sealed with a lamella and nail polish. 
Slides were observed under a fluorescence microscope Axio Imager Z1 
microscope (Zeiss). Images were acquired at x200 and x400 magnification with 
AxioVision software. 
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3.2.5. Cell cycle analysis by FACS 
Loss of control over cell proliferation is regarded as one of the most important 
traits of cancer. Therefore, it is necessary to study cell proliferation and cell cycle activity 
in tumor cells. A significant improvement in these studies was achieved by the 
introduction of the technique of Fluorescence-activated cell sorting (FACS) analysis 
(Eidukevicius et al., 2005). 
FACS is a technique used for the analysis of multiple parameters of different types 
of cells within heterogeneous populations. This is based upon the passage of cells through 
a laser excitatory beam, capturing the fluorescence emitted by each labeled cell as it 
passes along the laser and analyses the quantity and intensity of the fluorescence, 
converting the information to histograms (Macey, 2007). 
With this technique it is possible to quantify the DNA of the cells stained with 
propidium iodide (PI), a fluorescent DNA intercalating dye that binds to cells. This 
analysis allows to recognize four distinct phases of the cell cycle - G1, S, G2, M phases 
– in a proliferating cell population. However, G2 and M phases cannot be distinguished 
(Cecchini, Amiri, & Dick, 2012; Macey, 2007). 
Cells (1x107) were synchronized by starvation, being cultured in 40 mL of RPMI 
1640 medium (BE12-167F, Lonza) supplemented with 1% AA (15240062, Anti-Anti, 
Invitrogen) and L-Glutamine 200 mM (25030-024, Gibco, Life Technologies), at 37°C 
and 5% CO2 without FBS. After about 8 h, cell pellets were collected (time point 0) and 
the medium was supplemented with 1% of FBS (S 0615, Biochrom). Afterwards, cells 
were collected at different time points: 2, 4, 8, 26, 32 and 50 h after FBS stimulation. 
Each cell samples were harvested at each time point and washed twice with PBS 
cell and pellets were fixed and permeabilized in 500 µL of ethanol 70% (v/v). After that, 
100 µL propidium iodide solution (50 µg/mL) (Appendix A) was added to each sample, 
followed by incubation at 37°C for 40 min. Samples were washed with PBS and 
centrifuged at 1200 rpm for 5 min at 4°C. 
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Finally supernatants were discarded and cells were ressuspended in 200 µL PBS 
0.1% (w/v) BSA (Appendix A) and analyzed by FACS (FACScalibur, Becton Dickinson). 
All samples were made in triplicates. 
FACS analysis was performed in FlowJo software. In this analysis, dead cells and 
aggregated cells were excluded. 
 
3.2.6. Cell death (apoptosis and necrosis) analysis by FACS 
Apoptosis is a carefully regulated process of cell death that plays an important 
role in tissue homeostasis. This physiological process, unlike necrosis or accidental cell 
death, is characterized by some specific morphological and biochemical changes that, 
such as nuclear chromatin condensation and fragmentation, cytoplasmic shrinkage and 
compaction, loss of plasma membrane asymmetry (Allen, Hunter, & Agrawal, 1997; 
Darzynkiewicz et al., 1992; Duvall & Wyllie, 1986; Kroemer, Petit, Zamzami, Vayssière, 
& Mignotte, 1995; Lincz, 1998; van Engeland et al., 1998). 
Phosphatidylserine (PS) is an important phospholipid membrane component, 
located on the surface of the cell membrane of normal live cells. However, when a cell 
undergoesapoptosis, PS naturally flips from the intracellular side to the extracellular 
surface of the cell, resulting in the exposure of PS to external cellular environment (van 
Engeland et al., 1998). 
Annexin V was shown to interact strongly and specifically with PS which allows 
a quick and reliable detection method of apoptosis by targeting the loss of plasma 
membrane asymmetry.  
Propridium iodide (PI), a nucleic acid binding dye which cannot penetrate live 
cells and apoptotic cells, can stain dead cells by binding tightly to the nucleic acids from 
the cell. The simultaneous use of Annexin V and PI allows the discrimination of intact 
cells (Annexin−/PI−) from early apoptotic cells (Annexin+/PI−), late apoptotic cells 
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(Annexin+/PI+) and necrotic cells (Annexin−/PI+) (van Engeland et al., 1998; Vermes et 
al., 1995). 
Within the context of the present thesis, apoptosis assay was performed to identify 
potential differences in the cell death and apoptosis patterns of the tumor cell lines 
isolated from the mice exposed to different diets (normal and fat diet) and due to the 
occurrence of tumor in different organs (BM, CNS and skin). 
Cells were plated in 48 plate tissue dishes at a 1x104 cells/mL concentration, with 
300 µL of RPMI 1640 medium (BE12-167F, Lonza) supplemented with 1% AA 
(15240062, Anti-Anti, Invitrogen) and L-Glutamine 200 mM (25030-024, Gibco, Life 
Technologies), at 37ºC and 5% CO2 without FBS. After about 8 h, 1% of FBS was added 
(S 0615, Biochrom).  
Cells were collected at 0 h and 24 h and centrifuged at 1200 rpm for 2 min and 
washed with 500 µL PBS 0.2% (w/v) BSA (Appendix A). Afterwards, samples were 
resuspended in 100 µL of annexin V binding buffer (Appendix A), stained with 1 µL 
FITC Annexin V (640906, Bio Legend) and 1 µl PI solution (50 µg/mL). Samples were 
incubated for 5 min at room temperature in the darkand then analyzed by FACS 
(FACScalibur, Becton Dickinson). All samples were performed in triplicates. 
FACS data analysis was performed in FlowJo software.  
 
3.2.7. Statistical analysis 
Results were analyzed by 2-way ANOVA to evaluate its statistical significance, 
using GraphPad Prism 6 software. Results were considered significant when ‘p-value < 
0.05’. 
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4. Results and discussion 
 
4.1. Study of CSF from patients with and without CNS metastasis by 
1H NMR spectroscopy 
The work presented on this chapter aims to study the CSF from cancer patients 
with and without cell invasion to the CNS based on a metabonomic approach using NMR 
technique. This includes the compositional analysis of these samples using both 
unsupervised and supervised multivariate analysis. 
 
4.1.1. 1H-NMR profiling  
As mentioned in section 3.1., 1H-NMR spectra were obtained from a total of 186 
samples of CSF, in which 176 were from patients without cell invasion in the CNS 
(control samples) and the other 10 samples were from patients diagnosed with cell 
invasion in the CNS. Typical spectra of these two groups are shown in Figure 4, some of 
the metabolites identified are indicated. We were able of identify 48 metabolites in the 
CSF spectra, 40 of them present in all samples (the metabolites are listed in Table 7 with 
its corresponding chemical shifts).  
Some of the metabolites, for example lactate and glucose, were immediately 
identifiable in the spectra. In the case of these two metabolites, it is clear differences in 
their content between the two groups, suggesting that the metabolic profiles of CSF 
samples with and without the presence of tumor cells are significantly different. 
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Figure 4 – Representative 1H NMR spectra for (A) control samples and (B) cell invasion samples, with some of the most intense metabolites identified. 
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Table 7 – Full list of the metabolites identified in CSF samples and respective signals.  
Metabolites δ 1H (ppm) 
Alcohols ethanol 1.11 (t), 3.61 (q) 
glycerol 3.55 (m), 3.64 (m), 3.78 (tt) 
methanol 3.34 (s) 
propylene glycol * 1.13 (d), 3.43 (dd), 3.58 (dd), 3.87 (m) 
Amino acids alanine 1.46 (d), 3.76 (q) 
arginine * 1.68 (m), 1.90 (m), 3.23 (t), 3.76 (t) 
citrulline * 1.56 (m), 1.87 (m), 3.14 (q), 3.74 (dd) 
glutamine 2.04 (m), 2.12 (m), 2.34 (m), 3.75 (dd) 
glutamate 2.12 (m), 2.45 (m), 3.77 (t) 
glycine 3.54 (s) 
histidine 3.16 (dd), 3.23 (dd), 3.98 (dd), 7.09 (d), 7.90 (d) 
isoleucine 0.93 (t), 0.997 (d), 1.25 (m), 1.46 (m), 1.97 (m), 3.66 (d) 
leucine 0.95 (t), 1.70 (m), 3.72 (m) 
proline * 1.99 (m), 2.06 (m), 2.34 (m), 3.33 (dt), 3.41 (dt), 4.12 (dd) 
methionine * 2.16 (m), 2.63 (t), 3.85 (dd) 
lysine 1.46 (m), 1.71 (m), 1.89 (m), 3.02 (t), 3.74 (t) 
valine 0.97 (d), 1.03 (d), 2.26 (m), 3.60 (d) 
phenylalanine 3.19 (m), 3.98 (dd), 7.32 (d), 7.36 (m), 7.42 (m) 
threonine 1.31 (d), 3.58 (d), 4.24 (m) 
tryptophan 3.29 (dd), 3.47 (dd), 4.07 (dd), 7.19 (m), 7.27 (m), 7.31 (s), 7.53 (d), 7.72 (d) 
tyrosine 3.02 (dd), 3.17 (dd), 3.92 (dd), 6.88 (m), 7.17 (m) 
Organic acids 2-hydroxyisovalerate 0.82 (d), 0.95 (d) 
2-hydroxybutyrate 0.89 (t), 1.64 (m), 1.73 (m), 3.99 (m) 
3-hydroxyisobutyrate 1.11 (d), 2.65 (m), 3.69 (m) 
3-hydroxyisovalerate 1.26 (s), 2.35 (s) 
3-hydroxybutyrate 1.20 (d), 2.31 (ABX), 2.41 (ABX), 4.18 (ABX) 
3-methyl-2-oxovalerate 0.90 (t), 1.10 (d), 1.46 (m), 1.70 (m), 2.93 (m) 
acetate 1.91 (s) 
acetoacetate 2.27 (s), 3.43 (s) 
ascorbate 3.33 (m), 4.01 (m), 4.50 (d) 
lactate 1.32 (d), 4.10 (q) 
citrate 2.53 (d), 2.65 (d) 
formate 8.44 (s) 
pyruvate 2.46 (s) 
succinate * 2.39 (s) 
Sugars glucose alpha: 3.40 (t), 3.52 (dd), 3.70 (t), 3.75 (m), 3.82 (m), 3.83 (ddd), 5.22 (d) 
beta: 3.23 (dd), 3.39 (t), 3.45 (ddd), 3.48 (ddd), 3.71 (dd), 3.88 (dd), 4.63 (d) 
fructose 3.58 (m), 3.70 (m), 3.82 (m), 3.90 (dd), 4.01 (m), 4.03 (dd), 4.12 (m) 
mannose 3.37 (dd), 3.58 (t), 3.65 (m), 3.74 (m), 3.80 (m), 3.84 (m), 3.88 (dd), 3.92 (m), 5.17 (d) 
myo-inositol 3.26 (t), 3.52 (dd), 3.61 (t), 4.05 (t) 
Others acetaminophen * 1.97 (s), 6.66 (d), 7.32 (d), 9.11 (s), 9.63 (s) 
acetone 2.22 (s) 
choline 3.18 (s), 3.50 (dd), 4.05 (ddd) 
creatine 3.02 (s), 3.92 (s) 
creatinine 3.03 (s), 4.05 (s) 
dimethyl sulfone * 3.14 (s) 
urea 5.78 (s) 
xanthine 7.89 (s) 
 
*, metabolites found only in some samples. 
s, singlet; d, doublet; dd, doublet of doublets, ddd,  doublet of doublet of doublets; t, triplet; m, multiplet; ABX, ABX pattern. 
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4.1.2. Multivariate analysis of control samples 
After the spectra processing step mentioned in 3.1.2.4., explorative analysis was 
performed by multivariate analysis on the entire spectral dataset of control samples. For 
all samples some clinical information was supplied: the type of primary tumor, gender 
and age (children/adult), according to Table 1. 
Both age and gender are being increasingly recognized as important factors 
influencing CNS structure and function. However, there are relatively few data on actual 
neurochemical differences between the sexes in human subjects or on their interaction 
with age (Zubieta, Dannals, & Frost, 1999). 
Principal component analysis (PCA), an unsupervised analysis, is the most widely used 
multivariate analysis method in metabolic fingerprinting and chemometrics in general. The 
objective of PCA is to achieve a linear transformation that preserves as much of the variance in 
the original data as possible, in the lower dimensionality output data (Jolliffe, 2002). 
PCA analysis was applied to the NMR data of 176 CSF samples (control samples). 
In the Figure 5 are represent the PCA score plots (PC1 vs PC2) of control samples dataset 
with each point (or spectrum) colored according the age of the patient, providing a map 
of how the points relate to each other. 
 
Figure 5 – PCA score plot of the two first PCs using 1H-NMR data of control samples (n=176) 
and colored according to age (77 adults and 99 children). PC1 = 46.3 % and PC2 = 6.93 %. 
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The PCA analysis based on the age of the patients shows that the sub-group 
children have a tendency to be separated from the adults sub-group along the PC2. This 
indicates that children and adults have different metabolic profiles. The discrimination 
between the two groups is based in the content of some metabolites. Formate, tyrosine, 
ascorbate, myo-inositol, arginine, creatinine, glutamine, acetate, lactate, 3-
hydroxybutyrate, ethanol, isoleucine, leucine and valine are increased in the children (and 
consequently decreased in the adults); while glucose, glycerol, citrate, alanine and others 
metabolite(s) unidentified are found decreased in the children and increased in the adults 
(Figure 6). 
 
Figure 6 – PCA loading plot of PC2 using 1H-NMR data of adults samples of control samples with the 
metabolites that are found increased (positive part of PC2) and decreased (negative part of PC2) in the 
children and that are increased (negative part of PC2) and decreased (positive part of PC2) in the adults. 
 
To explore the discrimination of children samples from adults’ samples, 
supervised methods were applied. This type of approach may facilitate the discovery of 
the largest discrimination between two groups, in contrast to unsupervised methods 
(PCA) that only allow identifying the main sources of variability within a data set. 
The Orthogonal Partial Least Squares Discriminant Analysis (OPLS-DA) model 
using the class identity age as response variable (Y) was obtained, with one predictive 
and three orthogonal components. Cumulative explained variance (R2Y) of 0.726 and 
goodness of prediction (Q2) of 0.511 were obtained by the model, which is higher than 
the empirically inferred acceptable value of ≥ 0.4 for a biological model. This result is 
visually represented in the OPLS-DA score plot (Figure 7), where most of the samples 
are separated from each other by the value 0. These results suggest that the metabolite 
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composition of the CSF from children and adults is different, although the influence of 
this parameter appears be limited. 
 
Figure 7 – OPLS-DA score plot of the first and the orthogonal components using 1H-NMR data of control 
samples (n=176), colored according to the age of the patients (77 adults and 99 children). R2Y (cum) = 
0.726 and Q2 (cum) = 0.511. 
 
The loadings for this model indicated the metabolites that contribute for this 
separation are: formate, histidine, tyrosine, glucose, ascorbate, myo-inositol, acetate, 
lactate, 3-hydroxybutyrate, valine, isoleucine and leucine are increased in the children 
and consequently decreased in the adults; while mannose, glycerol, citrate, alanine and 2-
hydroxybutyrate are found decreased in the children and increased in the adults (Figure 
8). 
When comparing this results to the ones obtained in the loading plot of PCA 
(Figure 6), it is possible to see that most of the metabolites that are varying are the same 
in the two analyses, i.e. formate, tyrosine, ascorbate, myo-inositol, acetate, lactate, 3-
hydroxybutyrate, isoleucine and leucine are increased in the children and glycine, citrate 
and alanine are increased in the adults. However, glucose is increased in children in PCA, 
but decreased in OLPS-DA. 
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Figure 8 – OPLS-DA loading plot of PC1 using 1H-NMR data of control samples (n=176), with the 
metabolites that are found increased (positive part of PC1) and decreased (negative part of PC1) in the 
children and that are increased (negative part of PC1) and decreased (positive part of PC1) in the adults. 
 
 
These results coincide with the results previously obtained in other studies. 
Because ethical considerations prohibit subjecting young infants to a potentially painfully 
procedure (ie, lumbar puncture) before they are able to assent, the number of studies 
regarding children are limited. 
It is known that a healthy neonate’s CSF protein concentration is normally 2 to 3 
times higher than an adult and declines between birth and early childhood. The most rapid 
rate of decline is thought to occur in the first 6 months of life as the infant’s blood-CSF 
barrier matures (Statz & Felgenhauer, 1983). Immaturity of the blood-CSF barrier is 
thought to result in higher CSF protein concentrations for neonates and young infants 
when compared with older children and adults (Bonadio et al., 1992; Wong et al., 2000). 
But since lumbar punctions are only performed when required by physicians, there could 
be a limitation that could potentially lead to the inclusion of infants with conditions 
associated with higher CSF protein concentrations (Shah et al., 2011) 
For the adults, CSF total protein concentrations were found increased with age: 
elderly had higher concentrations than the young (May et al., 1990). 
Daners and co-workers (2012) also verified that in healthy humans, age 
significantly influences various components of cerebral arterial blood flow and CSF 
dynamics (Daners et al., 2012). 
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Since there are differences between children’s CSF and adults CSF, the further 
analysis was performed taking into account these differences. For each sub-group, two 
other clinical parameters (gender and type of primary tumor) were analyzed. 
Figure 9 and Figure 10 show the PCA scores plot of the two first PCs based on 
the gender of children (n=99) and adults (n=77), respectively. In both situations, no 
differences are clear between the groups. This indicates that a large source of the variance 
in the data does not correspond to these two sub-groups. It is important to mention that 
further PCs also did not show clusters either. There is no clustering of male and female 
CSF samples in both children and adults group (Figure 8 and 9, respectively). 
 
 
Figure 9 – PCA score plot of the two first PCs using 1H-NMR data of children samples (n=99) and colored 
according to gender (58 males and 41 females). PC1 = 43.8 % and PC2 = 6.19 %. 
 
male 
female 
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Figure 10 – PCA score plot of the two first PCs using 1H-NMR data of adults samples (n=77) and colored 
according to gender (39 males and 38 females). PC1 = 52.7 % and PC2 = 6.19 %. 
 
These results do not agree with some obtained previously, in other studies. Zubieta 
and co-workers (1999) in a study with healthy patients observed that gender is an 
important variable to consider in the interpretation of investigations related with the CNS 
since women’s reproductive status (reproductive age versus postmenopausal) may 
influence the function of CNS opioid systems (Zubieta et al., 1999). Yasuda and co-
workers (1991) also verified differences in the CSF production rate between male and 
female. Hagenfeldt and co-workers (1984)  also found sex differences in CSF amino acid 
levels (Hagenfeldt et al., 1984). Stoop and co-workers (2010) in a metabolomics and 
proteomic analysis of normal CSF samples concluded that high inter-individual variance 
is influenced by gender only in a limited way (Stoop et al., 2010). In contrast, Schiffer 
and co-workers (1999) found diferences in the CSF density of males and females (Schiffer 
et al., 1999).  Meissner and co-workers (2014) in a study about complex regional pain 
syndrome (CRPS)-related dystonia using NMR for the metabolic profiling of the CSF of 
patients with this disease verified that the PCA model did not reveal associations 
according to gender (Meissner et al., 2014).  
male 
female 
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Other parameter analyzed was the origin of the primary tumor. In the case of 
children (n=99), this group is mainly composed by leukemia (83 out of 99) and by a small 
number of other types of primary tumor (13 lymphomas, 2 rhabomyosarcoma and 1 germ 
cell tumor) (Figure 11). Interestingly, the last types of primary cancer are on the negative 
part of PC2, but there are also lymphomas cases populating that axe. The small number 
of samples that are not from leukemia precluded to take more conclusions. 
 
 
Figure 11 – PCA score plot of the two first PCs using 1H-NMR data of children samples (n=99) and colored 
according to the type of primary tumor (13 lymphoma, 83 leukemia, 2 rhabdomyosarcoma, 1 germ cell 
tumor). PC1 = 43.8 % and PC2 = 6.19 %. 
 
For the adults (n=77), the majority is also from lymphomas (46 out of 77) and 
leukemia (21 out of 77), but there are other types of primary tumor (5 breast carcinoma, 
1 non-melanoma skin cancer, 1 multiple myeloma and 1 colorectal cancer). In this case, 
most of the variability is explained by PC1 (Figure 12). As observed for the children sub-
group, there is no clustering based on the type of primary tumor and consequently there 
are no differences at metabolic level for this clinical parameter. 
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Figure 12 – PCA score plot of the two first PCs using 1H-NMR data of adults samples (n=77) and colored 
according to the type of primary tumor (46 lymphoma, 21 leukemia, 5 breast carcinoma, 1 non-melanoma 
skin cancer, 1 multiple myeloma and 1 colorectal cancer). PC1 = 52.7 % and PC2 = 6.19 %. 
 
 
4.1.3. Multivariate analysis of control and cell invasion samples 
A first preliminary analysis using PCA model using all samples 1H NMR dataset 
was performed. Figure 13 show the correspondent PCA score plot, with each point 
colored according to the presence or absence of cell invasion in the CNS. It is possible to 
observe a tendency for the samples originated from cell invasion patients separated from 
the controls. These results suggest that the metabolite profile of the control samples is 
somewhat different from the samples with cell invasion to the CNS. 
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Figure 13 – PCA score plot of the two first PCs using 1H-NMR data of all samples (n=99) and colored 
according to the presence or absence of cell invasion in the CNS. PC1 = 44.8 % and PC2 = 11.3 %. 
 
To explore the discrimination between the two groups of samples, supervised 
methods (OPLS-DA) were applied.  
Since previous analyses concluded that there are differences between the 
metabolic profile of children, this OPLS-DA model is only applied to the sub-group of 
adults samples (n=77), from which 9 are samples with cell invasion. For children this 
model in not applied since in this case there is only one case of cell invasion to the CNS. 
The OPLS-DA score plot of the first and the orthogonal components using the 
class controls and cell invasion as response variable (Y) showed a cumulative explained 
variance (R2Y) of 0.626 and goodness of prediction (Q2) of 0.327, which is not higher 
than the empirically inferred acceptable value of ≥ 0.4 for a biological model (Figure 14). 
In this plot there aren’t two clear separated clusters, however the control samples are 
majorly distributed in the center of the plot and the cell invasion samples are majorly 
found in the positive part of PC1. These results suggest that there are some differences 
between the metabolic composition of CSF in the absence and presence of cells in the 
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CSF, but this parameter influence appears limited. There could be others factors that 
influence this result, including the small number of samples included in this study. 
 
 
Figure 14 – OPLS-DA score plot of the first and the orthogonal components using 1H-NMR data of 
controls and cell invasion samples from the sub-group of adults (n=77). R2Y (cum) = 0.626 and Q2 (cum) 
= 0.327. 
 
 
The PCA analysis based on the control and cell invasion samples shows that cells 
invasion group have a tendency to be separated from the controls along the PC1. The 
metabolites that contribute for this separation are: histidine, phenylalanine, tyrosine, 
glucose, glutamate, acetate, lactate, 3-hydroxybutyrate, isoleucine, leucine, valine and 
other unidentified metabolites are increased in the control samples; xanthine, glycine and 
citrate are increased in the cell invasion samples (Figure 15). 
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Figure 15 – OPLS-DA loading plot of PC1 using 1H-NMR data of control and cell invasion samples 
(n=77), with the metabolites that are increased (positive part of PC1) and decreased (negative part of PC1) 
in the cell invasion samples and that are increased (negative part of PC1) and decreased (positive part of 
PC1) in the control samples. 
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4.2. In vitro study of CNS metastasis in human acute lymphoblastic 
leukemia (697-GFP) cell line 
 
The work presented on this chapter aims at studying the tumor progression and 
the importance of tumor’s microenvironment in a leukemia murine model exposed to 
different diets (normal and fat diet) using different approaches including metabolomics, 
gene and protein expression and analysis of cell cycle and apoptosis. 
 
4.2.1. Luminescence analysis 
Luminescence analysis was performed by our collaborators in the Instituto de 
Medicina Molecular. This analysis allows monitor the disease burden. Mice exposed to 
a fat diet have more extensive disease spread and colonization of organs by leukemia 
cells than the mice exposed to a normal diet (Figure 16). 
This evidence suggests that cholesterol plays an important role in cancer 
progression and development. Cholesterol is a highly insoluble molecule that is 
transported in the circulation via endogenous transporters, the lipoproteins. They are 
responsible for the mediation of the processing and delivery of dietary and endogenous 
cholesterol to systemic tissues and the uptake of cholesterol from the blood stream by the 
liver, allowing the homeostatic cholesterol balance. In cancer, it has been found that HDL 
(high density lipoprotein) are the most affected by malignant tumor development 
(Muntoni et al., 2009) and that LDL (low density lipoprotein) may play a fundamental 
role in cancer progression via supplying malignant cells and tumors with cholesterol to 
most peripheral tissues via the LDL-receptor (Brown & Goldstein, 1986; Silvente-Poirot 
& Poirot, 2012). Other studies have revealed that lipoproteins can enhance the 
aggressiveness of malignant tumors in mouse models (Danilo & Frank, 2012).  
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Figure 16 – Luminescence analysis of tumor cells from 697-GFP lineage in mice exposed to a normal diet 
(on the left) and in mice exposed to fat diet (on the right). The scale shows the grade of disease burden. 
This analysis was performed by our collaborators in the Instituto de Medicina Molecular. 
 
 
Normal diet High cholesterol diet 
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4.2.2. Metabolic profiling by NMR spectroscopy  
 
As mentioned in section 3.2.2, 1H NMR spectra were obtained from a total of 9: 
aqueous extracts, organic extracts and supernatants, in which 1 was from the parental 
lineage, 1 from mice with tumor on the skin and exposed to normal diet (named S), 1 
from mice with tumor on the brain and exposed to normal diet (named B), 3 from mice 
with tumor on the skin and exposed to fat diet (named S1, S2 and S3) and 2 from mice 
with tumor on the brain and exposed to fat diet (named B1 and B2). 
The representative NMR spectra for the aqueous extracts, organic extracts and 
supernatants are shown in Figure 17. Aqueous extracts and supernatants are majorly 
composed by amino acids, organic acids and sugars. Organic extracts are majorly 
composed by different lipids. There are some metabolites that couldn’t be identified. 
The spectra were analyzed by multivariate analysis (PCA) on the entire spectral 
dataset for the cells extracts (aqueous and organic) and supernatants, taking into account 
the localization of tumor metastasis and the type of mice diet. 
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(A) 
 
 
 
 
 
(B) 
 
 
 
 
 
(C) 
 
Figure 17 – Representative 1H NMR spectra of (A) culture medium (B) aqueous extract and (C) organic extract, with some of the metabolites 
identified. 
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In the PCA score plots of the two first PCs (PC1 vs PC2) for the supernatants is 
not observable the formation of clusters considering the localization of tumor metastasis 
or the mice diet (Figure 18 and Figure 19, respectively). In addition, further PCs also did 
not show independent clusters when taking into account these information’s.  
 
Figure 18 – PCA score plot of the two first PCs using 1H-NMR data of supernatants (n=9) and colored 
according to the localization of tumor metastasis on the mice (1 parental lineage, 3 brain metastases, 4 
skin metastasis and 1 bone marrow metastasis). PC1 = 43.5 % and PC2 = 22.6 %. 
 
 
 Figure 19– PCA score plot of the two first PCs using 1H-NMR data of supernatants (n=9) and colored 
according to the type of mice diet (1 parental lineage, 3 normal diet and 5 fat diet). PC1 = 43.5 % and 
PC2 = 22.6 %. 
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Lipid metabolism is a complex metabolic network involved in many aspects of 
cancer cell biology. Lipids production is a prerequisite for cell growth and proliferation, 
but in cancerous cells they are also active players in the signaling processes that are 
involved in cell transformation and tumor development. They also appear to have a 
potential role in facilitating the spread of cancer cells to secondary sites, but this 
phenomenon is not yet fully understood (Baenke et al., 2013). 
Figure 20 and Figure 21 is observed that there is no clustering of samples based 
on the local of metastasis or mice diet in the PCA score plots (PC1 vs PC2) of organic 
extracts. These results show that there aren’t significant differences at metabolic level 
between the organic extracts from brain, skin and bone marrow and from normal and fat 
diet. Interestingly, despite be result of only one sample of the parental 697-GFP cell line, 
appears that the lipid content of the cells lineages isolated from the mice are different 
from the parental cell line. 
 
 
Figure 20 – PCA score plot of the two first PCs using 1H-NMR data of organic extracts (n=9) and 
colored according to the localization of tumor metastasis on the mice (1 parental lineage, 3 brain 
metastases, 4 skin metastasis and 1 bone marrow metastasis). PC1 = 57.4 % and PC2 = 29.6 %. 
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Figure 21– PCA score plot of the two first PCs using 1H-NMR data of organic extracts (n=9) and colored 
according to the type of mice diet (1 parental lineage, 3 normal diet and 5 fat diet). PC1 = 57.4 % and PC2 
= 29.6 %. 
 
No clustering is observed, when the same analysis is performed to the aqueous 
extracts, considering the localization of tumor metastasis (Figure 22). This means that 
there are no significant differences at metabolite level between the aqueous extracts from 
brain, skin and bone marrow.  
 
 
Figure 22 – PCA score plot of the two first PCs using 1H-NMR data of aqueous extracts (n=9) and 
colored according to the localization of tumor metastasis on the mice (1 parental lineage, 3 brain 
metastases, 4 skin metastasis and 1 bone marrow metastasis). PC1 = 41.9 % and PC2 = 20.8 %. 
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However, considering the type of mice diet, the plot suggests that normal diet and 
fat diet form two different clusters (Figure 23). With the fat diet samples are placed 
tendentiously on the positive part of PC2, while the normal diet samples on the negative 
part of PC2. This plot suggests that the metabolic profile of the aqueous extracts from 
cells of mice exposed to normal diet is different from the cells of mice exposed to fat diet. 
These differences are explained by PC2, the second PC that represents most of the 
variance between samples.  
 
 
Figure 23 – PCA score plot of the two first PCs using 1H-NMR data of aqueous extracts (n=9) and colored 
according to the type of mice diet (1 parental lineage, 3 normal diet and 5 fat diet). PC1 = 41.9 % and PC2 
= 20.8 %. 
 
In the loading plot correspondent to PC2, it is possible observe that formate, 
glucose, creatine, glutamine, lactate, isoleucine, leucine, valine and other unidentified 
metabolite are increased the mice exposed to fat diet while ADP, choline, creatinine, 
aspartate, glutamate are increased in the ones exposed to normal diet (Figure 24). 
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Figure 24 – PCA loading plot of PC2 using 1H-NMR data of aqueous extracts with the identification of 
the metabolites that are increased (positive part of PC2) and decreased (negative part of PC2) in the cells 
from mice exposed to fat diet and that are increased (negative part of PC2) and decreased (positive part 
of PC2) in the cells from mice exposed to normal diet and from parental lineage. 
 
One of the most significant differences between aqueous extracts from cells of 
mice with the two types of diets is the presence of glucose inside the cells of mice exposed 
to a fat diet. The relationship between dietary fat and glucose metabolism has been 
recognized for at least 80 years. The first studies about the possible effect of dietary fat 
on glucose metabolism in animals and humans were published by Himsworth (1935), 
where he concluded that “the glucose tolerance of a healthy individual is determined by 
the composition of the diet which he is receiving” (Himsworth, 1935). In experimental 
studies with animals it was seen that high fat diets result in impaired glucose tolerance 
(Lichtenstein & Schwab, 2000). Other studies have concluded that dyslipidemia (abnomal 
concentrations of lipids in the peripheral blood) is associated to tumor growth and 
metastasis (Alikhani et al., 2013; Kimura & Sumiyoshi, 2007; Scholar, Violi et al., 1989). 
 
4.2.3. Gene and protein expression levels 
The role of fat diet in leukemia growth and metastasis in mice models was 
evaluated in 697-GFP parental cell lines and in cells isolated from mice maintained in 
normal and fat diet grown in RPMI 1640 supplemented with glutamine and 10% FBS.  
The expression levels of glucose transporters (SGLT1 and GLUT1) in parental 
lineage (control condition), in skin fat diet lineage (cells from mice exposed to fat diet 
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that metastasized to the skin) and in skin normal diet lineage (cells from mice exposed to 
normal diet that metastasized to the skin) was assessed by Real Time-PCR (Figure 25). 
 
Figure 25 – Relative gene expression of SGLT1 and GLUT1. 18S gene was the endogenous control. 
Expression levels were normalized to parental lineage. Data are mean ± error bars of triplicates. * p ≤ 
0.05 ; ** p ≤ 0.01. 
 
Glucose is transported into cells by two families of transporters: a facilitative-type 
glucose transporter family (GLUT) and an active-type glucose transporter family 
(sodium/glucose cotransporter (SGLT)) (Wood & Tryhurn, 2003). 
SGLT1 plays an important role in maintaining enough glucose for cell survival 
since it transports glucose into cells regardless of glucose concentration in the medium. 
Cells are dependent on this transporter to accumulate and maintain higher intracellular 
glucose levels (Wright et al., 1994). The presence of SGLT1 allows cancer cells to uptake 
enough glucose for ATP generation via glycolysis (Nishimura et al., 1998). In this study, 
SGLT1 were statistically increased in the cells from mice exposed to fat diet in relation 
to the other two cell lines. This may indicate that SGLT1 contributes significantly to the 
entry of glucose into these cells. 
GLUT1 is responsible for serving many cell types for glucose uptake and is 
expressed ubiquitously in human tissues. Elevated expression of this transporter has been 
documented in most cancers (Airley & Mobasheri, 2007; Baer et al., 1997; Macheda et 
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al., 2005; Smith, 1999; Zierler, 1999). In this study, GLUT1 was found statistically 
increased in cells of mice exposed to both diets, when comparing to the parental cell line. 
These results suggest that this gene does not play a role in cells from mice with fat diet 
though it may be relevant to select cancer cells in vivo (in mice).  Previous studies 
demonstrated that higher levels of expression of this transporter is observed in cancers of 
higher grade and proliferative index, since the more aggressive tumors probably have a 
greater demand for metabolic energy and consequently, a greater demand of glucose 
(Cantuaria et al., 2001; Higashi et al., 1998; Ravazoula et al., 2003; Younes et al., 1995). 
Accordingly, cancer cells to systemically survive in an animal model must have enough 
plasticity to adapt to the new environment. Hence, GLUT1 can be a key element in cancer 
selection in vivo, allowing glucose uptake and survival of cells that are able to express it. 
By Real Time-PCR it was also assessed the gene expression levels of IDH1 and 
IDH2, which corresponding enzymes belong to Kreb’s cycle (Figure 26). These enzymes 
are homodimeric enzymes that act in the cytoplasm and mitochondria, respectively, to 
produce NADPH by the conversion of isocitrate to α-ketoglutarate (Cairns et al., 2011). 
 
Figure 26 – Relative gene expression of IDH1 and IDH2. 18S gene was the endogenous control. Expression 
levels were normalized to parental lineage. Data are mean ± error bars of triplicates.* p ≤ 0.05. 
 
The gene expression levels of IDH1 was increased in parental cells and in cells 
from mice exposed to fat diet in relation to the ones from mice maintained in a normal 
diet. For IDH2 expression, no statistically significant differences were found between the 
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three cell lines. Recent studies demonstrate that specific mutations in IDH1 and IDH2 are 
linked to the regulation of cancer cell growth in glioblastoma (Parsons et al. 2008) and 
acute myeloid leukemia (AML) (Mardis, 2009). Such mutations are expected to limit the 
function of the TCA cycle and consequently increase the glycolytic dependence of these 
tumors, since it synthesizes preferentially the oncometabolite 2-hydroxyglutarate, 
reducing the rate of α-ketoglutarate synthesis to supply Kreb’s cycle. It is likely that 
tumors with these types of mutations could be especially vulnerable to management 
through dietary energy restriction, since it could inhibit multiple signaling pathways 
required for progression of malignant tumors regardless of tissue origin (Seyfried & 
Shelton, 2010). However, in the studied cell lines the mutational profile of IDH1 and 
IDH2 was not assessed and it may further clarify our results. 
It was also investigated the gene and protein expression levels of genes involved 
in lactate metabolism (LDHA, LDHB, LDHC) and transport (MCT1 and MCT4). 
The reversible pyruvate reduction into lactate reaction is catalyzed by the LDH 
family of tetrameric enzymes. This reaction also allows glycolytic cells to maintain the 
levels of pyruvate low enough to avoid cell death (Thangaraju et al., 2006, Thangaraju et 
al., 2008), since it is converted into lactate and exported to extracellular media. The 
biochemical features of LDHA and LDHC favor the conversion of pyruvate into lactate 
whereas those of LDHB favor the conversion of lactate into pyruvate (Ganapathy et al., 
2009). While LDHA and LDHB are expressed in somatic mammalian tissues, LDHC is 
only found expressed in testis and sperm (Holmes & Goldberg, 2009). In addition, 
different combinations of LDHA and LDHB subunits constitute the 5 LDH tetrameric 
(homo and hetero tetramers) isoforms, whereas LDHC subunit only constitute a single 
homotetrameric enzyme. In some types of tumors, production of lactate also occurs in 
response to genetic features and to stimuli from the tumor microenvironment (Draoui & 
Feron, 2011; Xiong et al., 2011). Lactate production is necessary for sustaining glycolysis 
at a high rate (Ganapathy et al., 2009). Expression levels of LDHA, LDHB and LDHC 
have been found increased in several types of cancer (Kinoshita et al., 2011; Koslowski 
et al., 2002; Lewis et al., 2000; Walenta & Mueller-Klieser, 2004). Lactate is also 
considered an alternative metabolic fuel for cancer cells, being oxidized into pyruvate, 
the last metabolite of glycolytic pathway and entering the Kreb’s cycle as acetyl-CoA. 
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In this study, the relative mRNA levels of LDHA, LDHB and LDHC enzymes are 
shown in Figure 27. The protein expression levels obtained by western blot only for 
LDHB are shown in Figure 28.  
 
Figure 27 – Relative gene expression of enzymes involved in lactate metabolism LDHA, LDHB and 
LDHC. 18S gene was the endogenous control. Expression levels were normalized to parental lineage. Data 
are mean ± error bars of triplicates. * p ≤ 0.05 ; ** p ≤ 0.01. 
 
 
Figure 28– LDHB protein levels assessed by western blot. Protein levels were normalized to β-actin and 
are relative to those obtained in the parental lineage. 
 
At mRNA level, for LDHA there is statistically significant differences between 
parental lineage and both cells from mice under fat and normal diets, which is in 
concordance with results obtained by other authors that found increased levels of LDHA 
in invasive melanoma cancer (Agarwala et al. , 2009; Bedikian et al., 2008) in more 
advanced adenocarcinomas (Beer et al., 2002). Interestingly, this result is in agreement 
with the increased expression levels of GLUT1 in both cells from mice under fat and 
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normal diets, since a high rate of glucose uptake allows an increased glycolysis rate and 
consequently lactate production catalysed by LDHA subunit. 
Expression levels of LDHC are not statistically different between cell lineages. 
LDHC has been recently found expressed in a broad spectrum of human tumors, with 
high frequency in lung cancer, melanoma, breast cancer (Koslowski et al, 2002) and in 
some prostate cancers (Tang & Goldberg, 2009).  
Expression levels of LDHB did not reveal statistically significant differences 
between parental lineage and both cells from mice exposed to normal and fat diet. Despite 
no differences were observed in gene expression, at protein level it was observed a 
slightly increase of LDHB in cells from mice exposed to normal diet, comparing to the 
other two cell lineages. However, protein measurement by densitometry was only 
performed in a single replicate, being necessary a further analysis in two more replicates 
in order to certify the results. Nevertheless, discrepancies between mRNA and protein 
levels can be observed often due to diverse post-transcriptional mechanisms that are 
involved in turning the mRNA into protein (mRNA degradation) or due to the different 
in vivo protein half-life resultant from protein synthesis and degradation (Greenbaum, 
Colangelo et al., 2003). Moreover, recent data as shown that LDHA was overexpressed 
in neoplastic cells and the expression of LDHB was downregulated (Singer et al., 2011). 
Anyway, the quantification of native tetrameric enzymes (LDH1 to 5) will give rise to 
more clear conclusions about the predominant LDH activity, since as mentioned before 
the functional enzymes are combinations from LDHA and/or LDHB subunits. This 
quantification will be further performed by ELISA (Enzyme-Linked Immunosorbent 
Assay). 
Lactate is transported by monocarboxylate anion transporters, the MCTs 
(Halestrap & Price, 1999). MCT1 regulates preferentially the entry of lactate into tumor 
cells whereas MCT4 preferentially exports lactate out of the cell (Draoui and Feron, 
2011). Studies have demonstrated that these two transporters are overexpressed in 
neuroblastoma, colorectal cancer, cervix cancer and lung tumor metastatic cells, 
indicating bad prognosis (Fang et al., 2006; Izumi et al., 2011; Pinheiro et al., 2008, 2009; 
Sonveaux et al., 2008). 
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The relative mRNA levels of MCT1 and MCT4 transporters are shown in Figure 
29. The protein expression levels for MCT1 and MCT4 obtained by western blotting are 
shown in Figure 30 and by immunofluorescence is shown in Figure 31.  
 
Figure 29 – Relative gene expression of lactate transporters MCT1 and MCT4. 18S rRNA gene was the 
endogenous control. Expression levels were normalized to parental lineage. Data are mean ± error bars 
of triplicates. *** p ≤ 0.001. 
 
 
Figure 30 – MCT1 and MCT4 protein levels assessed by western blot. Protein levels were normalized to 
β-actin and are relative to those obtained in the parental lineage. 
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Figure 31 – Immunofluorescence for MCT1 and MCT4 (green) in parental lineage, skin fat diet lineage, 
skin normal diet lineage, brain fat diet lineage, brain normal diet lineage and bone marrow normal diet 
lineage. Nuclei were labelled with dapi (blue). Fluorescence microscopy (magnification: 200x and 400x). 
 
A statistically significant increase of mRNA levels of MCT1 was observed in the 
tumor cells lineage from mice exposed to fat diet, when comparing to the parental lineage. 
Concerning protein levels of MCT1 assessed by western blotting, the dynamics was similar 
to the observed at the mRNA levels. In contrast, protein levels assessed by 
immunofluorescence only showed a decrease in MCT1 expression in cells from brain 
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normal diet, comparing to all the other lineages. However, despite being a more accurate 
method to quantify protein then immunofluorescence, western blotting must be performed 
in 3 replicates for all lineages, in order to ensure the results. This difference between mRNA 
and protein expression has been identified before (Kang, Im, Go, & Han, 2009). According 
to Greenbaum et al. (2003) this absence of correlation could be due to varied post-
transcriptional mechanisms that participate in turning mRNA into protein or that proteins 
expression may vary in in vivo (Greenbaum et al., 2003). Jackson et al. (1997) also reports 
little correlation between the mRNA and protein levels of MCT1 (Jackson et al., 2007). 
MCT1 is significantly increased in breast carcinomas when compared with normal 
breast tissue and has been associated with poor prognostic variables including high-grade 
tumors (Pinheiro et al., 2010). MCT1 expression has also been associated with advanced 
gastric carcinoma and lymph node metastasis (Pinheiro et al., 2009). 
Concerning MCT4, no differences cell lineages were observed at both protein 
(assessed by western blot and immunofluorescence) and mRNA levels. However, recent 
studies have suggested an association between MCT4 expression and primary tumor size, 
further infiltration, growth and resistance to cell death, in colorectal cancer (Gotanda et 
al., 2013) and in breast cancer (Whitaker-Menezes et al., 2011). 
Since in NMR analysis glucose was detected in certain cell extracts, the 
expression of key genes involved in gluconeogenesis was also analyzed in order to certify 
if some cells are synthesizing glucose. 
The mRNA levels of ALT, PCK1, PCK2, FBP1 and PFKFB1 was assessed by 
Real Time-PCR (Figure 32). 
By western blotting, only the protein expression levels of PCK1 and PFKFB1 
were evaluated, due to technical problems related to antibodies for ALT, PCK2 and FBP1 
(Figure 33). 
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Figure 32– Relative gene expression of gluconeogenic enzymes ALT, PCK1, PCK2, FBP1 and PFKFB1. 
18S rRNA gene was the endogenous control. Expression levels were normalized to parental lineage. Data 
are mean ± error bars of triplicates. 
 
 
Figure 33 – PCK1 and PFKFB1 protein levels assessed by western blot. Protein levels were normalized to 
β-actin and are relative to those obtained in the parental lineage. 
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Alanine is one of the gluconeogenic substrates which through transamination is 
converted into pyruvate. This reaction is catalyzed by alanine aminotransaminase (ALT). 
In this study, no differences were detected at mRNA level between the different cell 
lineages. However, studies have demonstrated higher levels of ALT in colorectal cancer 
patients with liver metastasis (Wu et al., 2012), which can be related to the fact that the 
liver is the main gluconeogenic organ as the ALT in those patients was measured in 
peripheral blood. 
In the expression of phosphoenolpyruvate carboxykinase cytosolic (PCK1) that 
catalyzes the main reaction in cytoplasmic gluconeogenesis, the conversion of 
oxaloacetate into phosphoenolpyruvate (Granner & Pilkis, 1990), the results obtained at 
mRNA level are different from those obtained at protein level. The relative gene 
expression is similar between the cell lineages. However, cells from both skin fat diet and 
skin normal diet mice revealed an increased protein expression in relation to the parental 
lineage. The absence of correlation between mRNA and protein levels could be a result 
of varied post-transcriptional mechanisms involved in convertion of mRNA into protein 
or due to the different in vivo half-lives of proteins resultant from protein synthesis and 
degradation (Greenbaum et al., 2003). Moreover, other studies have found that PCK1 
mRNA levels were significantly higher in the liver metastatic lesions in comparison to 
the primary pancreatic tumors (Chaika et al., 2012). Again the gluconeogenic expertise 
of the liver can be the key element in this observation. 
Phosphoenolpyruvate carboxykinase mitochondrial (PCK2) catalyzes the main 
reaction of mitochondrial gluconeogenesis, the conversion of oxaloacetate into 
phosphoenolpyruvate (Granner and Pilkis, 1990). mRNA levels show no significant 
differences between cell lineages. Studies suggest PCK2 may be associated with cell 
proliferation in hepatocelular carcinoma (Y.-X. Liu et al., 2012), that may be due to the 
fact that hepatocarcinoma cells retain the ability of normal hepatocytes of fulfilling 
gluconeogenesis. 
Fructose-1,6-bisphosphatase (FBP1) is the gluconeogenic enzyme that catalyzes 
the conversion of fructose-1, 6-biphosphate (F1,6BP) in fructose-6-phosphate (F6P) 
(Quintas et al., 2008). mRNA levels of this enzyme also show no differences between 
cell lineages. In the literature, this key enzyme is found silenced in gastric, liver and colon 
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cancer (Quintas et al., 2008). Accordingly, in a study about breast cancer, FBP1 
expression inhibited tumorigenicity in vitro and suppressed tumor formation in vivo 
(Dong et al., 2013).  
The last evaluated enzyme was PFKFB1, an enzyme associated with the 
promotion of glycolysis and the inhibition of gluconeogenesis through the activation or 
inhibition, respectively, of their kinase activity, being mainly expressed in the liver 
(Noguchi et al., 2013). In this study, no differences were verified at mRNA level between 
the different cell lineages. However, the results obtained by western blotting at protein 
level revealed that this enzyme was downregulated in cells skin fat diet and overexpressed 
in cells skin normal diet. The characterization of this enzyme expression profile, in cancer 
context, is not depicted in the literature (Ros & Schulze, 2013). 
 
In resume, in the mRNA levels of these gluconeogenic enzymes (ALT, PCK1, 
PCK2, FBP1 and PFKFB1) there aren’t statistically significant differences between the 
cell lineages in study. However, the protein analysis revealed that PFKFB1 was 
downregulated in cells from the skin of mice exposed to fat diet. Since this enzyme has 
its function associated with the promotion of glycolysis and the inhibition of 
gluconeogenesis through the modulation of their kinase activity (Noguchi et al., 2013), 
its inhibition may indicate that gluconeogenesis is one of the pathways involved in the 
accumulation of glucose inside of the cells of mice exposed to a fat diet.  
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4.2.4. Cell cycle analysis by FACS 
Increased proliferation is one of the hallmarks in cancer. Cell cycle analysis was 
performed to evaluate the effect of different diets on cell cycle proliferation in all cultures. 
This analysis revealed that the cell lineages in study do not present statically significant 
differences in cell cycle status for all the evaluated time points (Figure 34).  
Previous studies have indicated that high fat diet (LDL enriched) may be 
associated with an increased cell proliferation and cancer progression in prostate cancer 
(Huang et al., 2012) and in colon cancer (Liu et al., 2001). However, in our in vitro study 
this was not observed. Controversially, other data as shown that the addition of HDL to 
cell cultures increased the proliferation of human breast cancer cells (Uda et al., 2012). 
 
 
 
 
 
 
 
 
 
 
 
 
The metabolism of central nervous system metastasis: Cerebrospinal fluid metabolome 
  67 
 
 
 
Figure 34 – Cell cycle analysis by FACS (PI staining) in all cell lineages, at time point 0, 2, 4, 8, 26, 32 and 50 h. Data are 
means of triplicates. In brain fat diet lineage it is included the results of the two cultures and in skin fat diet is included the 
results of the three cultures. 
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4.2.5. Cell death (apoptosis and necrosis) analysis by FACS 
Another important area of interest is the study of active programmed cell death 
(apoptosis), compared with passive cell death (necrosis), due to the fact that resistance to 
apoptosis is one of the hallmarkers of cancer (Seyfried & Shelton, 2010). 
In this study, apoptosis and necrosis analysis was performed to all cell lines, at 0 
h and at 24 h (Figure 35). 
The percentage of cells in apoptosis and necrosis is very low, showing no 
significant differences between cell lineages at any evaluated time point. These results 
suggest that in the in vitro conditions evaluated in our study, the in vivo selection of cells 
with a diet rich in cholesterol does not increase resistance to cell death. In a study of breast 
tumor cells calorie restriction appeared to promote apoptosis, whereas consumption of a 
high fat diet reduced apoptosis (Dogan et al., 2007). Additionally, a study of prostate 
cancer cells in xenografts indicated that cholesterol elevation reduced apoptosis (Zhuang, 
et al., 2005). Nevertheless, in our study cells were exposed to fat diet in vivo but in vitro 
this selective pressure was not maintained. Hence, in order to confirm that resistance to 
cell death is an adaptive process and not a selectively acquired cell feature that become 
constitutive, additional experiments will be performed by culturing cell lineages in 
cholesterol enriched culture medium.  
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Figure 35 – Apoptosis (annexin V positive cells) and necrosis (PI positive cells) analysis by FACS, at time 
points 0 and 24 h. Data are means of triplicates ± error bars of triplicates. In brain fat diet lineage it is 
included the results of the two cultures and in skin fat diet is included the results of the three cultures. 
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5. Concluding Remarks 
 
The spread of cancer into the central nervous system (CNS) is a serious problem 
leading to neurological symptoms and rapid mortality. The ability to detect and 
characterize malignant cells in the cerebrospinal fluid (CSF) can help in understanding 
the biology of metastatic spread In addition to detecting cancer cells in the CSF through 
direct methods, studies have focused in the indirect detection of CSF malignancy through 
changes in expression patterns of proteins and metabolites in CSF samples. Since the 
current diagnostic tools available lack of sensitivity, metabolomic approach could be 
promising in detecting the earliest meaningful sign of neoplastic presence in the CSF 
(Schold, Wasserstrom, Fleisher, Schwartz, & Posner, 1980; Weston et al., 2011). 
Moreover, the determination of the CSF metabolome in cell invansion situation gives 
insights about the interaction of the tumoral cells and the CSF, and can help to explain 
the preference of some tumors for the CNS. 
Nuclear magnetic ressonance (NMR) analysis of CSF samples from patients 
without cell invasion revealed that the metabolic profile of CSF from children is different 
from adults. However, CSF composition is not affected by gender and primary tumor 
origin. 
The NMR analyses of CSF from patients with and without cell invasion indicates 
that there are differences between the two groups, but the number of CSF samples is still 
small to obtain a more concrete conclusion. 
The preliminary study of a leukemia murine model (697-GFP cell line) exposed 
to different diets (normal and fat diet) revealed that the metabolic prolile of the cells from 
mice exposed to fat diet is different from the ones exposed to a normal diet. In contrast, 
there are not significant differences between the metabolic profiles of these cells with 
different localizations of tumor metastasis. Gene and protein expression analysis of these 
cells suggests that gluconeogenesis may be one of the pathways that could underlie the 
differences found between the cells from mice exposed to different diets. 
The metabolism of central nervous system metastasis: Cerebrospinal fluid metabolome 
  71 
 
Overall, these studies may help in understanding the pathophysiology of this 
disease, including the site-specific properties of tumor cells and the CNS 
microenvironment. 
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6. Future Perspectives 
 
For the study of CSF from patients with and without metastasis in the CNS, it is 
necessary a bigger number of samples with cell invasion in other to clarify if there are 
differences between these two groups at metabolic level and which metabolites are 
responsible for that differences. In order, to extend our analysis, the utilization of other 
techniques, such LC-MS and GC-MS, would be useful. A proteomic analysis of the CSF 
is also planned to be performed in the near future. 
In the in vitro study of cancer metastasis using leukemia murine model (697-GFP 
cell line) exposed to normal and fat diet, it is necessary to perform gene and protein 
expression analyses to the others cell lineages (brain fat diet, brain normal diet and bone 
marrow normal diet). In addition, metabolic analysis by NMR of these cultures with 13C-
labeled glucose could be performed in order to better understand the metabolism of tumor 
cells and identify the main carbon source of tumor cells. 
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Appendix A 
 
Solutions prepared for the experimental work: 
 
 
10X PBS (pH 7.4-7.6) (Sambrook & Russel, 2001)  
For 1L:  
80 g NaCl (1.37 M) (106404, Merck)  
2 g KH2PO4 (14.7 mM) (104873, Merck)  
11.1 g Na2HPO4 (78.1 mM) (S-0876, Sigma)  
2 g KCl (26.8 mM) (104936, Merck)  
ddH2O to 1 L  
 
5X SDS gel loading buffer (Sambrook & Russel, 2001)  
250 mM Tris HCl (pH 6.8) (0.5M 161-0799, Bio-rad)  
10% SDS (V6551, Promega)  
0.5 % bromophenol blue  
50 % glycerol (1.04094.1000, Merck) 
 
15 % resolving gel and 5 % stacking gel for Tris-glycine SDS-Polyacrylamide 
Gel Electrophoresis prepared accordingly to Sambrook & Russel, 2001  
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Transfer buffer  
For 5 L:  
75 g glycine (US16407, USB)  
15 g Trizma-base (T-8524, Sigma)  
ddH2O to 4 L  
1 L Methanol (107018, Merck)  
5 mL 10% SDS (V6551, Promega) 
 
PBS with 0.1% (v/v) Tween 20  
For 1 L:  
1 mL Tween 20 (20605, USB)  
PBS to 1 L  
 
PBS with 0.2% (w/v) BSA  
0.4 g BSA (A9647, Sigma)  
200 mL PBS  
 
5% (w/v) skimmed milk in PBS 0.1% (v/v) Tween 20  
5 g skimmed milk (Molico, Nestlé)  
100 mL PBS 0.1% (v/v) Tween 20 
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50 µg/mL Propidium Iodide (PI) solution – Cell cycle assay  
For 50 mL:  
1 mL of 2.5 mg/mL PI solution (P4170, Sigma) (prepared in PBS)  
49 mL PBS  
0.1 mg/mL RNase A (Easy spin kit, Citomed)  
0.05% Triton X-100 (T8787, Sigma) 
 
RIPA buffer  
For 10 mL:  
20 mM Tris-HCl pH 7.5  
150 mM NaCl (106404, Merck)  
5 mM KCl (104936, Merck)  
5 mM MgCl2 (M-8266, Sigma)  
1% Triton X-100 (T8787, Sigma)  
ddH2O to 10 mL  
1 Complete, Mini, EDTA-free Protease Inhibitor Cocktail Tablet (11836170001, 
Roche)  
1 mM Orthovanadate (Na3VO4)  
1 mM Sodium fluoride (NaF) (201154, Sigma)  
 
Annexin binding buffer 
0.01 M Hepes (pH 7.4) (391333, Millipore)  
0.14 M NaCl (106404, Merck)  
2.5 mM CaCl2 (449709, Sigma) 
 
